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ABSTRACT
BACKGROUND: The purpose of this study was to explore both positive screened MDD
and the perception of being depressed (P) and the likelihood of either increasing if the
patient suffered from arthritis (P/E), either perceived or evaluated by a physician. The
study explored the univariate, bivariate, and multivariate relationships between MDD and
depression (P) to better describe influencing characteristics and their prevalence, as
related to MDD and depression (P).
METHODS: The study examined a cross section of patients 65 years and older (n=8,205)
within the National Epidemiologic Survey on Alcohol Abuse and Alcoholism (NESARC)
[2001-02] sponsored by the National Institute on Alcohol Abuse and Alcoholism
(NIAAA). A multivariate analysis was conducted using SAS Callable SUDAAN to
account for the complex design of the study and adjusted odds ratios (ORs) of modeling
were computed to account for Models 1-4.
RESULTS: Those persons age 65 and older who report having arthritis (P/E) were
significantly more likely to be suffering from MDD than those who have not reported
having an arthritic condition (P/E) [results were positive within Models 2-4]. Those
persons age 65 and older who report having arthritis (P/E) were not significantly more
likely to be suffering from depression (P) than those who have not reported having an
arthritic condition (P/E) [results were negative within Models 2-4].
This creates significant concern, given that each of the multivariate models (2-4)
examined arthritis (P/E) while utilizing the same control variables throughout. Further,
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many of the relationally significant variables in the MDD versus depression (P) models
were not the same (Table 4.4 /4.5).
CONCLUSION: This study demonstrated a significant difference within the senior
population between those with arthritis (P/E) and those who have positively screened
MDD and depression (P). Seniors with arthritis (P/E) seem to respond differently with
regards to positively screened MDD and depression (P). The results demonstrated
conclusive evidence that one cannot count on an elderly patient to have a positive
perception of depression as it relates to being positively screened for MDD. Further, it
would appear that older persons may not disclose whether or not they are depressed in a
clinical environment. This becomes important to clinicians and further demonstrated the
need for clinically valid assessment measures to ensure preventative measures are being
taken to address elderly depression.

vi

TABLE OF CONTENTS
DEDICATION ........................................................................................................................ iii
ACKNOWLEDGEMENTS ........................................................................................................ iv
ABSTRACT .............................................................................................................................v
LIST OF TABLES ................................................................................................................... ix
LIST OF FIGURES ....................................................................................................................x
CHAPTER 1: INTRODUCTION

..................................................................................................1

1.1 PROBLEM STATEMENT ...............................................................................................1
CHAPTER 2:

LITERATURE REVIEW ........................................................................................9

2.1 CONTRIBUTIONS OF THE STUDY .................................................................................9
2.2 THE EPIDEMIOLOGY OF MDD ....................................................................................11
2.3 THE DSM-IV CRITERIA FOR MDD (IN CONTEXT) ........................................................12
2.4 QUALITY PROBLEMS IN COMMONLY USED ASSESSMENTS.........................................16
2.5 QUALITY PSYCHOPHARMACOLOGY AND THE DIAGNOSIS .........................................21
2.6 QUALITY STANDARDS IN EVALUATION, TREATMENT, AND REFERRAL ......................23
2.7 PRIMARY CARE PHYSICIANS’ ROLE IN MDD ..............................................................25
2.8 THEORETICAL FRAMEWORK.....................................................................................26
2.9 CHARACTERISTICS OF THE POPULATION AGED 65 AND OLDER .................................47
2.10 CHRONIC CONDITIONS OF THE US POPULATION AGED 65 AND OLDER .....................51
2.11 COSTS ASSOCIATED WITH THE OLDER POPULATION ...............................................56
2.12 INTRODUCTION TO DEPRESSION .............................................................................58

vii

2.13 INTRODUCTION TO ARTHRITIS. ..............................................................................61
2.14 RESEARCH QUESTIONS/HYPOTHESIS ......................................................................66
CHAPTER 3:

METHODS ........................................................................................................67

3.1 DATA SOURCE AND STUDY POPULATION ..................................................................67
3.2 STUDY VARIABLES ...................................................................................................67
3.3 ANALYTICAL APPROACH ..........................................................................................82
CHAPTER 4:

RESULTS .........................................................................................................84

4.1 DESCRIPTION OF THE POPULATION ...........................................................................84
4.2 DESCRIPTION / BIVARIATE ANALYSIS [MDD] ............................................................85
4.3 MULTIVARIATE ANALYSIS [MDD] ..........................................................................101
CHAPTER 5:

DISCUSSION ..................................................................................................109

5.1 BACKGROUND .......................................................................................................109
5.2 SUMMARY .............................................................................................................109
5.3 LIMITATIONS OF THE STUDY ..................................................................................110
5.4 CONCLUSIONS........................................................................................................111
5.5 RECOMMENDATIONS..............................................................................................111
REFERENCES ......................................................................................................................114

viii

LIST OF TABLES
Table 3.1 Coding of Major Depression Criteria among Population
65 Years and Older ............................................................................................................71
Table 3.2 Blended Conceptual Framework Control Variable Categorization ...................75
Table 4.1 Predisposing Characteristics and Risk Factors for Major
Depression (MDD).............................................................................................................88
Table 4.2 Biopsychosocial Characteristics and Risk Factors for Major
Depression (MDD).............................................................................................................92
Table 4.3 Medical Comorbid Characteristics and Risk Factors for Major
Depression (MDD).............................................................................................................95
Table 4.4 Overlap Between MDD and Depression (P)......................................................97
Table 4.5 Factors Associated with MDD Among Population 65 Years and Older .........101
Table 4.6 Factors Associated with Depression (P) Among Population 65
Years and Older ...............................................................................................................105

ix

LIST OF FIGURES
Figure 2.1 Maslow’s Hierarchy of Needs (1943) / National Prevention
Strategy (2011)...................................................................................................................32
Figure 2.2 Kubler-Ross Stages of Grief (1969) / Transactional Self
Actualization (2013) ..........................................................................................................35
Figure 2.3 Andersen’s Health Services Conceptual Framework
Model (1995) .....................................................................................................................38
Figure 2.4 House’s (1981) Conceptual Framework: Paradigm of
Stress Research ..................................................................................................................39
Figure 2.5 House’s Conceptual Framework for Understanding Social
Inequities (2001) ................................................................................................................40
Figure 2.6 Andersen (1995) / House’s (1981, 2001) Blended
Conceptual Framework Model ..........................................................................................44

x

CHAPTER ONE: INTRODUCTION
1.1 PROBLEM STATEMENT
Depression extends its reach to both the social and economic impact with
disregard to geographic boundaries. The World Health Organization (WHO) reports that
depression is the leading cause of disability as measured by Years Lived with Disability
(YLDs) and the fourth leading contributor to the global burden of disease in 2000
("Report on Mental Illness" 2001). Additionally, in 2012, the WHO identified that
depression impacts 350 million persons worldwide. By the year 2020, depression is
projected to reach second place of the ranking of Disability Adjusted Life Years
(DALYs) calculated for all ages and for both sexes ("Report on Mental Illness" 2001).
Economically, depression displays similar crippling statistics as it relates to businesses
and their ability to sustain productive employees. Depression results in more
absenteeism than almost any other physical disorder and costs the U.S. employers more
than $51 billion per year in absenteeism and lost productivity, not including high medical
and pharmaceutical bills ("The Societal Promise of Improving Care for Depression"
2004).
The critical combination encompassing disability and cost stimulates the focus of
my concern on the elderly population and its growing numbers within the United States.
Since 1900, the percentage of Americans 65+ has tripled (from 4.1 percent in 1900 to
12.8 percent in 2008), and the absolute number of older persons has increased twelve
times (from 3.1 million to 38.9 million) ("A Profile of Older Americans: 2009" 2009).
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The elderly population’s massive growth is a tribute to technological and medical
advances, however the increases in age allow for longer periods of chronic and disabling
diseases. Some type of disability (sensory disability, physical disability, or mental
disability) was reported by 52 percent of older persons in 2002 ("A Profile of Older
Americans: 2007" 2007).
Moreover, the elderly adult also has an increased likelihood to suffer from
arthritis and other rheumatic conditions (AORC) due to the processes of aging.
According to the Centers of Disease Control and Prevention (CDC), arthritis is the
leading cause of disability in the U.S. and is associated with substantial activity
limitation, work disability, reduced quality of life, and high healthcare costs. Arthritis is
expected to affect an estimated 67 million adults in the U.S. by 2030 (Hootman &
Helmick 2006), and a 2003 report generated by the CDC suggests total cost of AORC to
be $128 billion, 1.2 percent of the gross domestic product (GDP) during that year (Yelin
et al. 2007). The CDC also suggests the prevalence of doctor-diagnosed arthritis among
adults was estimated at 21.6 percent, or 46.4 million persons. Prevalence was higher
among women (25.4 percent) compared with men (17.6 percent), older age groups (50
percent for persons aged >65 years and 29.3 percent for persons aged 45 to 64 years)
compared with younger age groups (7.9 percent for persons aged 18 to 44 years).
In 2004, 36.7 percent of noninstitutionalized persons age 65 and older claimed
their health was good or excellent (Chop 2009). The majority (80 percent) of elderly
persons have at least one chronic condition (Chop 2009). In 2002-2003, the most
frequently occurring conditions among older adults were hypertension (51 percent),
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diagnosed arthritis (48 percent), heart disease (31 percent), cancer of any type (21
percent), diabetes (16 percent), and sinusitis (14 percent) (Chop 2009).
As the population of the U.S. ages, the portion of that population with AORC and
MDD will increase. Appropriate treatment methods are needed to focus both on
physiologic care as well as palliative care for those suffering from AORC. My
hypothesis suggests an increased likelihood for those elderly who suffer from AORC to
also suffer from major depressive disorder (MDD) if appropriate preventative treatment
and/or palliative care are not administered. If treatment is overlooked, the combined
societal costs to treat elderly persons suffering from both AORC and MDD will be
significant.
1.1.1 AGING POPULATION
Demographics:
In 1900, only 4 percent, or 1 in 25, of Americans were older than 65 years of age
(Chop 2009). In 2008, the older population numbers 38.9 million and represented 12.8
percent of the U.S. population (over one in every eight Americans). The number of older
Americans has increased by 4.5 million or 13.0 percent since 1998, compared to an
increase of 12.4 percent for the under-65 population. However, the number of Americans
aged 45-64 – who will reach 65 over the next two decades – increased by 31 percent
during this period ("A Profile of Older Americans: 2009," 2009). The population of
those older than 65 years has increased by more than 2 million people (7 percent of the
population) since 1990, while the younger-than-65 age group increased by only 4 percent
(Chop 2009). A child born in 2007 could expect to live 77.9 years, about 30 years longer
than a child born in 1900. Life expectancy at age 65 increased by only 2.5 years between
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1900 and 1960, but has increased by 4.2 years from 1960 to 2007 ("A Profile of Older
Americans: 2009" 2009). Projections for the year 2030 estimate that 22 percent, or 70.2
million, of Americans will be older than the age of 65. An even more dramatic aging
trend exists among those older than 85 years of age, often referred to as the old-old. This
age cohort is expected to double – from 4.7 million in 2003 to 9.6 million in 2030 – and
double again to 20.9 million in 2050 (Chop 2009). The percentage of persons age 85 and
over is growing faster than any other age group (Haber 2010) while the average life
expectancy for an infant born in the United States (U.S.) today is 77 years, a dramatic
increase from 1900, when life expectancy was 47 years (Hetzel & Leeder 2001).
1.1.2 DEPRESSION
Prevalence:
It is estimated that by 2030, more than 15 million older adults will experience a
mental illness. That is nearly double the current number (Jeste et al. 1999). One-quarter
of today’s older adults experience some mental disorder, including dementia. About 16
percent have psychiatric disorders, and about 10 percent have dementia. A third of those
with dementia exhibit psychosis and/or depression, and they represent about 3 percent of
the total elderly population (Jeste et al. 1999). An estimated 46.4 percent of Americans
will experience some form of mental illness in their lifetime (Kessler et al. 2005). Given
a current U.S. population of more than 305 million, that figure represents an estimated
141 million Americans.
Lifetime prevalence of depressive disorders range from 5 percent to 17 percent
(Williams et al. 2002) and depression is projected to become the second leading cause of
disability worldwide by the year 2020. Prevalence estimates of depression vary based on
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the particular dataset, control variables, and the analysis/impact of comorbid
relationships. The risk of depression in the elderly increases with other illnesses and
when the ability to function becomes limited. Estimates of major depression in older
people living in the community range from less than 1 percent to about 5 percent, but
rises to 13.5 percent in those who require home healthcare and to 11.5 percent in elderly
hospital patients (Hybels & Blazer 2003). A lifetime prevalence rate for major
depression of 16 percent was identified for those in age ranges between 18 and above
(Kessler et al. 2003). It was also determined that all age ranges below 60 years of age
were more likely to experience lifetime major depression than those 60 years and above
(Kessler et al. 2003). Moreover, another study also suggested the lifetime prevalence of
major depression was 17 percent, however, the age ranges used were 15-54 years of age
(Blazer 1994). A separate study focused on nursing home patients while producing a
major depression prevalence rate of 17 percent. (Davison et al. 2007). While other
studies identify point estimates, 30-day prevalence rates, and 12-month instances of
major depression, the focus of this study is on the older population, and the lifetime
prevalence rates of major depression as it related the DSM-IV criteria-based
measurements.
Chronic Conditions/Comorbidity:
The most likely causes of depression in later life are the loss of a spouse or other
family support, chronic medical conditions and pain, loss of functional independence;
and difficulty adapting to changing circumstances within the home, family, or living
situation (Lantz 2002). These emotional and physical losses not only can lead to
depression, but depression in turn can lead to disease, physical decline, and disability
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(Brenes et al. 2008). Social phobia was the most common comorbid disorder among
elderly with depression, and depression was the most common comorbid disorder among
the elderly with any of the anxiety disorders (Cairney et al. 2008). Although comorbid
relationships exist and are well documented between depression and physical health
conditions and dementia, comorbid relationships also exist with regards to anxiety in the
elderly population (Cairney et al. 2008). Comorbid anxiety disorder diagnoses were
present in nearly 51 percent of patients with major depression (Fava et al. 2000).
Comorbid anxiety disorders both precede and follow major depression while their
influence on depression remains apparent (Fava et al. 2000). Causality, from an
epidemiological standpoint, is difficult to identify given the subjective diagnosis within
psychological evaluation. It is important to recognize that comorbid psychological
effects exist within diagnosis without particular understanding of causality.
1.1.3 ARTHRITIS
Prevalence:
Arthritis is the nation’s most common cause of disability and comprises more than
100 different rheumatic diseases and conditions, the most common of which is
osteoarthritis. Arthritis affects all race and ethnic groups: 36 million whites, 4.6 million
blacks, 2.9 million Hispanics, 280,000 American Indians/Alaska Natives, 667,000
Asian/Pacific Islanders, and 469,000 multiracial/others (Bolen et al. 2010). According to
the CDC, 46 million (22 percent) of adults have self-reported doctor-diagnosed arthritis
and 19 million (9 percent of all adults) have arthritis and arthritis-attributable activity
limitation. By 2030, 67 million (25 percent) adults aged 18 years and older will have
doctor-diagnosed arthritis and estimated 25 million adults (37 percent) of those with

6

arthritis will report arthritis-attributable activity limitations. These results were analyzed
by the CDC in review of the National Health Interview Survey (NHIS) from data
collected between 2007-2009 (Health Data Interactive 2011).
Costs/Impact:
In 2003, the total cost of arthritis was $128 billion, including $81 billion in direct
costs (medical) and $47 billion in indirect costs (lost earnings) [Yelin et al. 2007]. This
total is equal to 1.2 percent of the 2003 U.S. gross domestic product. Each year, arthritis
results in 992,100 hospitalizations and 44 million outpatient visits. 8.2 million working
aged U.S. adults (about 1 in 20) report work limitations due to arthritis or joint symptoms
while Blacks and Hispanics with arthritis have almost twice the prevalence of work
limitation and severe pain compared to Whites (Theis et al. 2007).
1.1.4 PURPOSE OF THE STUDY
The purpose of this study is to identify those positively screened for major
depression within the older population (> 64 years of age) and identify whether or not the
older population are more susceptible to major depression (MDD) if they acknowledge
being diagnosed for arthritis (E) by a physician in the past twelve months or perceive
themselves to have some form of arthritis(P). The dissertation will also suggest the
unique sense of its contribution with regards to the identification of practitioner-based
concerns and the particular variance from clinical diagnosis through differential diagnose
(DSM-IV requirement) by substituting instead of complementing treatment decisions by
utilizing assessment tools. The study will also identify the differences between those
who report being told they have been diagnosed arthritis from a physician and those who
perceive they suffer from the condition of arthritis. Additionally, the study will control
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for factors which are correlated to or may influence the results while attempting to secure
both validity and reliability within the study design.
1.1.5 SIGNIFICANCE OF THE STUDY
The proposed research makes the following contributions: First, the study follows
a medical model approach by utilizing the exact criteria from the DSM-IV to identify
those elderly persons who suffer from major depression. This is quite different from the
subjective questioning of the patient given that the exact diagnostic criteria determine the
patient’s diagnosis and not the subjective response of the patient. Secondly, the sample
size is large enough to be representative of the entire U.S. population. This provides a
representative outcome-based study that can be generalized across the population of the
nation for which the sample was drawn. The study will also provide clarity regarding a
descriptive account and variance between an individual’s perception (P) of feeling
depressed and meeting the actual DSM-IV criteria for MDD. Finally, the NESARC
dataset provided many control variables which nearly match the alternate risk factors for
the interaction between major depression and arthritis. These variables will be controlled
for in order to best represent the “true relationship” between major depression and
arthritis.
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CHAPTER TWO: LITERATURE REVIEW
2.1 CONTRIBUTIONS OF THE STUDY
This dissertation will attempt to examine the intended elements within the DSMIV (APA 2000), as it relates to Major Depressive Disorder (MDD) and express concerns
for the field given the current standardized assessments and their reliance with regarding
to evaluation, treatment, and referral. Additionally, as technological advances in
pharmacological dependency in treatment has increased, the impact regarding drug
interactions, as well as specificity of psychotropic medications, has created a systemic
concern for both patient safety as well as overall effective treatment within the mental
health community. A focus on technological innovation and clinical management in
mental health practice and policy would provide an improvement in overall treatment
effects. This is dependent on both clinical adherence (appropriate diagnosis/treatment
recommendations), as well as patient adherence (particularly in pharmacological
interventions). Both should be measured and accounted for, while clinical interventions
should utilize similar technologically managed care systems to prevent any future
medical errors to include lack of treatment, under-treatment, mistreatment, and
overtreatment in mental health clinical practice settings, as described by the American
Psychiatric Association (APA).
Moreover, this dissertation selected a specific nationalized dataset (NESARC)
including those >64 years of age to evaluate MDD (descriptively), as it relates to the
perception (P) of being “depressed” (self-reported) and those who positively screen by
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DSM-IV criteria (E) for MDD. This dissertation is attempting to establish the case
through a nationalized sample that perhaps a perception of being “depressed” in primary
care may be enough of an indicator to establish rationale to begin the evaluation,
treatment and referral process review given that much relies on the “diagnostic”
processes (differential diagnosis as suggested by the DSM-IV) and the need for
“screening” and not reluctant tendencies to “assess” in primary care and ensure that the
clinical standards and DSM-IV standards are being met and not the sub-categorical
categorization of an assessment created from the DSM-IV standards itself.
The study will attempt to provide detailed results between the perception of being
depressed (P) and positively screened MDD diagnosis of the DSM-IV. Additionally,
those either perceived to be suffering from arthritis (P) or those self-reporting to have
been diagnosed by a physician for arthritis (E) with be studied providing data regarding
the comorbid conditions between MDD and arthritis and their correlation along with the
need to establish collaboration in evaluation, treatment, and referral (particularly focus on
the diagnosis and psychopharmacologic recommendations [between and within]) in order
to ensure that the right care, at the right time, at the right cost (Triple Aim) is done;
ensuring patient safety and quality.
In 2011, the American Psychiatric Association updated their “Practice Guidelines
for Treating Major Depressive Disorder (MDD)” (APA 2011) for which much of the
substantive support of the literary response and recommendations will be added within.
However, the “gold standard” for treatment guidelines and the need for clinical training
and competent decision-making (to include differential diagnosis) originates and follows
the recommendations of the DSM-IV (APA 2000). It is important to note that the DSM-

10

V (APA 2013) was officially publishing in 2013; following a review of MDD and mood
disorders, no significant changes impacting evidence-based decision making or
differential diagnosis requirements were made concerning MDD or the categorization of
mood disorders.
The study research question (Q1) and hypotheses (H1 – H3) can be found in
Section 2.14.
2.2 THE EPIDEMIOLOGY OF MDD
Early on, depression was viewed as a deficiency involving neurotransmitters,
particularly the “monoamines” serotonin , norepinephrine, and dopamine (Julien et al.
2011). There is also evidence of alterations of several neuropeptides, including
corticotropin-releasing hormone (DSM-IV 2000). In some depressed individuals,
hormonal disturbances have been observed, including elevated glucocorticoid secretion
(e.g., elevated urinary free cortisol levels or dexamethasone nonsuppression of plasma
cortisol) and blunted growth hormone, thyroid-stimulating hormone, and prolactin
responses to various challenge tests (DSM-IV 2000). Attention has now shifted on
intracellular processes, such as second messengers, and their function in the neuron. Two
of these second messenger functions are (1) to protect neurons from damage due to injury
or trauma and (2) to promote and maintain the health and stability of newly formed
neurons (Julien et al. 2011). This new way of “second messenger” thinking is referred to
as neurogenic theory of depression (Julien et al. 2011). Neurogenic theory believes (1)
existing neurons are able to “repair” or “remodel” themselves and (2) the brain is capable
of making new neurons. The hippocampus is where attention, concentration, and
memory is formed and the repair or creation of new neurons adds to the field of
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neuroscience theory (Julien et al. 2011). Stressful situations can reduce hippocampal
function and damage existing neurons (Julien et al. 2011). Antidepressants are known to
repair neurons and increase neuron creation (Julien et al. 2011). The second messenger
system targets the cAMP response-element-binding protein (CREB) [Julien et al. 2011).
CREBs protein increases in the hippocampus during chronic antidepressant treatment
further support the second messenger generation of new neurons (Julien et al. 2011).
Depression beginning in late life is associated with alterations is brain structure,
including periventricular vascular changes (DSM-IV 2000).
2.3 THE DSM-IV CRITERIA FOR MDD (IN CONTEXT)
The DSM-III (1983) was introduced to provide an evidence-based categorization
of mental illness in which highly trained clinicians could have a standardized method of
communicative collaboration and diagnostic criteria. The practical purpose for this
development was to bridge mental health with physical health for which physicians
utilized objective evidence (medical modeling) to diagnose the physical ailments of
persons and the overall combined health (physical and mental) were becoming important
as the development of treatment methods (pharmacology) could provide effective
interventions for medical and psychological patients alike. The DSM-IV (2000) was then
expanded upon to meet the growing body of evidence within mental health treatment
along with the rapidly expanding technological interventions (pharmacology) available to
those health practitioners for which whom would have more treatment choices and
selections to make and determine (diagnose/treatment) including a collaborative approach
to both physical and mental health treatment. With the latest version of the DSM series
arriving this year (DSM V 2013), it would seem that there are relative concerns regarding
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both the utilization of all practitioners and the DSM standards and practices, as it relates
to the diagnosis (specificity) and its impact on treatment (pharmacology) with an everincreasing focus pharmacologically on specificity and intensity of drug selection and its
interactions with other physical and mental health medications selected for treatment.
Since the NESARC dataset utilized the DSM-IV, I will discuss the interpretive
intentions of the DSM authors to best describe my dataset. It is important to note that the
DSM-IV cautions the use of categorization for diagnosis, however, it does not caution
against its use to utilize for research and educational purposes. The DSM-IV authors
express their sincere acknowledgement that the manual is the be utilized by highly skilled
clinicians in order to be understood as a diagnostic tool; this is given to its “ruling out”
etiology based on phenomenological ordering and the need to fully understand its
intention to review and fully consider the concept of differential diagnosis. Additionally,
the DSM-IV requires the understanding of specificity in diagnostic decision-making,
requiring the coding to extend past the differential diagnostic process into adding
“subtypes” and “specifiers”. This is most important, as later pharmacological
recommendations are not only made based on the diagnosis (most assessments test),
however, it must be differentially diagnosed, sub-typed, and have inclusion of specifiers
(where needed). The DSM-IV states, “subtypes define mutually exclusive and jointly
exhaustive phenomenological subgroupings within a diagnosis” and “specifiers are not
intended to be mutually exclusive or jointly exhaustive” (DSM-IV 2000). This fact will
be important, as I fully explain the diagnostic intentions of the manual and utilize MDD
and the “ruling out” process of differential diagnosis.
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From a larger perspective, from beginning to end, the classification of a patient
would be evaluated using a multiaxial assessment (Axis I – IV). The following are the
categorical alignment of each axis a clinician is to review in order to conduct a full and
proper assessment: (1) Axis I – Clinical Disorders (2) Axis II – Personality Disorders (3)
Axis III – General Medical Conditions (4) Psychosocial and Environmental Problems (5)
Global Assessment of Functioning [GAF]. The primary diagnosis typically reviewed is
clinical and the Axis III-IV are usually viewed as co-occuring or secondary diagnoses.
However, it is important, as in physiological conditions, to understand how each
condition may interact along with the treatment modality considered or previously
administered (therapeutic or drug interactions). It is also critical to understand that each
one of these conditions and its diagnosis must be clinically reliable and valid in order to
effectively administer and monitor pharmacological treatment. Traditional assessments
suggest that if the assessment “measures what it is supposed to measure” it is “valid” and
if it “consistently measures what it says it is going to measure” it is “reliable”. This is
dependent that the instrumentation has accounted for the clinical elements, particularly
when specificity is so critical for both diagnosis and treatment considerations (see
Sections 2.4 and 2.5).
During this review of the DSM-IV, I am simply going to review the complexities
of the category of “mood disorders” and the specific diagnosis of “MDD” (subcategory
within “mood disorders”). This is appropriate given our study question and hypotheses,
as well as a case review depicting the need for a “screening” tool (DSM-IV) in context
instead of the clinically used assessments tools (see Section 2.4).
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“Mood disorders” consist of the following sub-categorized “depressive
disorders”: (1) Major Depressive Disorder (MDD); (a) Single episode (b) Recurrent; (2)
Dysthymic Disorder (3) Depressive Disorder Not Otherwise Specified (NOS). “Mood
disorders” also consist of subcategorized “bipolar disorders”: (1) Bipolar I Disorder; (a)
single manic episode (b) most recent episode hypomanic (c) most recent episode manic
(d) most recent episode mixed (e) most recent episode depressed (f) most recent episode
unspecified; (2) Bipolar II Disorder (3) Cyclothymic Disorder (4) Bipolar NOS (5) Mood
Disorder Due to General Medical Condition (6) Substance Induced Mood Disorder (7)
Mood Disorder NOS. It is important to note the following three issues: (1) each of these
sub-conditions could have a detailed listing of specifiers to review (2) particular medical
conditions (neurological such as Parkinson’s Disease, Huntington’s Disease, Multiple
Sclerosis, Stroke, and Alzheimer’s Disease) have been linked to these particular
diagnoses [coded on Axis I and III] (3) differential diagnosis needs to take place to
include a collaborative review of all medications prior to treating with pharmacological
intervention(s).
Within the MDD diagnosis, all of the following diagnoses need to be “ruled out”
prior to reviewing criteria for the diagnosis of MDD: (1) mood disorder due to general
medical condition (2) substance-induced mood disorder (3) dementia (4) manic episodes
with irritable mood or mixed episodes (5) attention-deficit/hyperactivity disorder
[ADHD] (6) adjustment disorder with depressed mood (7) bereavement (8) depressive
disorder NOS [for those who do not meet criteria for duration or severity]. Again, each
suggested diagnosis needs to be expanded upon by sub-type and specifier in order to truly
“rule out” all DSM differential priorities indicated. Additionally, given the elderly cross-
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sectional sample within the study, “due to general medical condition”, “substance
induced mood disorder” (to include prescribed medical interactions) and “bereavement”
may be of particular interest for consideration. Next, five of nine categories would need
to be “met” (see Table 3.1) to include the following conditions: (1) symptoms do not
meet criteria for “mixed episode” (2) symptoms cause clinically significant distress or
impairment in social, occupational, or other important areas of functioning [GAF] (3)
symptoms are not due to direct physiological effects of a substance [drug of abuse or
medication] or general medical condition [link to MDD] (4) symptoms are not better
accounted for by bereavement [loss of a loved one, symptoms persisting longer than two
months or characterized by marked functional impairment, morbid preoccupation with
worthlessness, suicidal ideation, psychotic symptoms, or psychomotor retardation]
(DSM-IV 2000).
The DSM-IV also identifies the need for most mood disorders to provide both
episodic and course specifiers. This is particularly important to know when attempting to
prescribe medications considering that an accurate diagnosis identifying both a crosssectional identification of the particular issue and its severity as well as a longitudinal
(cyclical) history of stated diagnosis is needed. The DSM-IV provides “decision trees”
for clinical assistance for each category of disorders. These are added as appendixes near
the end of the manual in order to assist clinicians in proper diagnostic decision-making
(both clinical and family practice) and care planning.
2.4 QUALITY PROBLEMS IN COMMONLY USED ASSESSMENTS
A review of both the American Psychiatric Association (APA), “Practice
Guidelines for Treating Major Depressive Disorder (MDD)” [2010] and the American
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Academy of Family Physicians’ (AAFP) subsection regarding “Depression and Bipolar”
[2012] treatment and diagnostic recommendations leave much concern within regard to
the absence of both highly skilled clinical diagnostic review (partnered psychiatrist) and
the criteria-based assessment tools currently being accepted into practice. Many of these
assessment tools have been adapted to meet the ever-growing prevalence in mental health
concerns and the additive treatment modalities (pharmacology). Additionally, everincreasing documentation requirements have reduced the amount of time physicians have
with each patient, chronic care and treatment options (both physically, mentally, and a
combination of both) have expanded the complexities of treatment, and the expansive
relationship within drug interactions and their “specificity” lead to much concern for both
patient safety and the streamlining of “standards of practice” to “realities of care”.
Specificity and drug toxicity are alarming; for which drug developers have reviewed the
exact dosage, time release, toxicity, and specificity recommendations (which diagnosis
and subtyping receive what drug) for which abbreviated assessments do not meet the
recommendations of both the drug developer, the “standards of practice”; leaving
concerns within the realities of care (lack of treatment, under-treatment, mistreatment, or
over-treatment).
This study provides a differential diagnostic review of assessment tools (section
on the DSM-IV) while questioning abbreviated assessment tools and their interaction
with the rapid changes in psychopharmacology. Additionally, this study will attempt to
show that the perception (P) of either depression, and more specifically, arthritis (P) or
arthritis (E) evaluated with MDD, is an important difference from previous studies in that
the focus will be on the “standards of practice” (recognition and screening in a timely
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fashion for specificity in diagnosis) instead of the realities of care (focused on an
abbreviated assessment that disregards differential diagnosis and the partnering of a
highly skilled clinician to review [psychiatrist] or the recognition accountability to
address the need for highly skilled training at all levels below or the need to refer for
treatment).
The remainder of this section will address several of the current abbreviated
assessment tools being utilized to identify MDD in clinical practice. It is important
understand that the instruments (as written) cannot replace the highly skilled clinician, as
they do not account for either physical health (comorbid concerns or drug interactions) or
other mental health conditions (the “ruling out” process required in the DSM-IV).
Moreover, the percentiles expressed regarding “sensitivity” and “specificity” do not
represent the similar terminology described in the DSM-IV (specificity), as the
assessment is being reviewed for “sensitivity” and “specificity” based on the particular
questions within the assessment (limited) as they relate to MDD and not the depth of
diagnosis. The measurements do not account for inter-relationships within comorbid
treatment and drug selection, as well as drug “specificity” needed for appropriate
treatment selection; this is based on the “specificity” of the diagnosis as well as the
appropriate selection of the “sub-type” and the “specifier” from the DSM-IV.
The AAFP suggests the first instrument utilized in assessing a patient is the
Patient Health Questionnaire - 2 (PHQ-2). Their report and findings suggest that it is as
effective as the Beck Depression Inventory (BDI) and the Zung Depression Scale (ZDS).
The reported rate of specificity on this particular assessment tool is 67 percent with a
sensitivity rating of 97 percent. The PHQ-2 simply asks the following two questions
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(related to the two criteria discrediting the diagnosis of MDD in the DSM-IV [must have
either to have MDD]): (1) little interest (2) feeling down. There is some variance from
direct context within the DSM-IV regarding these two questions as the DSM-IV suggests
content specific to the following two categories: (1) depressed mood [sad/empty] and (2)
loss of interest or pleasure.
The AAFP then recommends, if positive, to utilize the PHQ-9. If the patient’s
age is >64 years, then administer the Geriatric Depression Scale (GDS) [15 item scale] as
well; this comes both recommended by the AAFP and the American Geriatric
Association (AGA). The PHQ-9 is reported to have a rating of 94 percent sensitivity and
61 percent specificity. Following a review of 18 studies (AAFP 2012), the GDS [15 item
scale] had a sensitivity rating between 74 and 100 while having a specificity rating
between 53 and 98. The particular questions within the PHQ-9 had those similar to the
criteria within the DSM-IV for MDD, however, they divided the responses into four subcategories: (1) not at all (2) several days (3) more than half days (3) nearly every day.
Additionally, the totals of the responses are added to create a final result attempting to
“detail” the severity of MDD: (1) 1-4 [minimal], (2) 5-9 [mild], (3) 10-14 [moderate], (4)
15-19 [moderately severe], and (5) [severe]. The GDS [15 item scale] has 15 questions
in which “yes/no” responses are given; the assessor understands which “yes/no” response
suggests a positive assessment towards MDD in which > 5 positive responses are
“suggestive of depression” and > 10 positive responses are “almost always depression”.
The AAFP then suggests that if either of these assessments are “positive” they should be
confirmed utilizing the DSM-IV and its criteria. However, we are making the distinction
that, given the environment of collaborative and quality care, meeting the “criteria” is not
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the standard of the DSM-IV. The standard of the DSM-IV is met through differential
diagnosis “above and beyond” the standard and the standard requires “sub-typing” and
“specifiers” for accurate diagnosis. However, it is important to understand that both the
assessment options and the AAFP recognize the DSM-IV as the final authority in
diagnostic care.
The APA focuses primarily on the four assessments: (1) PHQ-9, (2) Beck’s
Depression Inventory [BDI], the Hamilton Rating Scale for Depression [HAMD], and the
GDS. Given the AAFP recognized both the PHQ-9 and the GDS, we will not duplicate a
descriptor or the elements needed to understand both sensitivity/specificity and the
scoring of these assessments. The BDI is a 21 item assessment, quite detailed [scaling 03], with an overall scoring system as follows: (1) 1-10 [ups/downs considered normal],
11-16 [mild mood disturbances], 17-20 [borderline clinical depression], 21-30 [moderate
depression], 31-40 [severe depression], and over 40 [extreme depression]. The BDI was
the most comprehensive assessment reviewed, however, it did not account for
“differential diagnosis” within the instrument nor “rule out” the requirement to utilize the
DSM-IV for this purpose following a positive assessment. The HAMD is a 21 item
assessment tool that includes similar scales as the BDI. Conversely, the HAMD includes
some stratification to account for things such as personality disorder, somatic conditions,
and anxiety. However, it is important to note that none of the additional generalized
itemization is enough or conclusive to include diagnosis in these areas. The scales
included vary from smaller scales, such as 0-2 responses generally around secondary
diagnoses (such as personality disorders, somatic conditions, and anxiety) to more details
responses, such as 0-4, representing those characteristics surrounding MDD.
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The most compatible assessment (highly detailed) for clinicians and relative to the
comorbid complexities to include the review of DSM-IV criteria (including differential
diagnosis) is the Composite International Diagnostic Interview (CIDI 3.0) developed by
Dr. Ronald Kessler as supported by the World Health Organization (WHO). This
sectional reporting tool was developed for researchers in order to administer DSM-IV
appropriately reviewed diagnosis criteria to provide an actual account of validity in a
large researched population sample (later reviewed within the European Study of the
Epidemiology of Mental Disorders [ESEMeD 2007]. Although comprehensive in nature,
it was primarily constructed from research conditions or administered by highly trained
interviewers in sections. Additionally, the administration of sectional assessments are
time consuming making it difficult to clinically administer in a primary care setting or
one in which practitioners are assessing patients within a limited window of time.
2.5 QUALITY IN PSYCHOPHARMACOLOGY AND THE DIAGNOSIS
The purpose of this section of the dissertation is to identify the solutions,
challenges, and side effects of psychotropic and antidepressant drugs used in the
treatment of MDD. The brief review of psychopharmacology (science of how drugs
affect the body) [Julien et al. 2011] is needed in order to fully understand that particular
drugs and their effects in “intensity”, “release”, and “specificity” are relative to those
overall positive and negative effects in treatment.
“Pharmacokinetics” is the understanding of the basic principles of drug
absorption, distribution, metabolism, and excretion (Julien et al. 2011).
“Pharmacodynamics” examines the interactions between drugs and receptors to which the
drug attach as well as how the attachment results in alterations in cell function and
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behavior (Julien et al. 2011). Pharmacokinetics is made up of the four basic processes:
(1) absorption (2) distribution (3) metabolism (4) elimination (ADME) [Julien et al.
2011]. Concepts related to the four basic processes are: drug tolerance, drug dependence,
dosage, intensity and half-life. These terms have much to do with “time” and the impact
(effect) of the drug on the cellular processes and the body’s response to such
interventions. Drug absorption refers to processes and mechanisms by which drugs pass
from the external world into the bloodstream (Julien et al. 2011). Drug distribution is the
passing across various barriers in the bloodstream to reach its site of action (receptors)
[Julien et al. 2011]. The processes involved between the kidney and liver within drug
metabolism and elimination are complex; the important element is to understand that they
both are involved in metabolism and elimination and their rates of absorption and
excretion have an impact on overall drug effect.
Tricyclic antidepressants (TCAs) block the presynaptic transporter; commonly
referred to in its impact on chemical structures, as newer antidepressants are defined by
their mechanism of action (Julien et al. 2011). Some side effects of TCAs are as follows:
confusion, memory and cognitive impairment, dry mouth, blurred vision, increased heart
rate, dizziness and urinary retention (Julien et al. 2011). Monoamine oxidase inhibitors
(MAOIs) bind to and block the enzyme monoamine oxidase; this enzyme metabolizes
and regulates the amount of the biogenic amine transmitters in the presynaptic nerve
terminal (Julien et al. 2011). TCAs and MAOIs are referred to as first-generation
antidepressants. In the late 1980s, selective serotonin reuptake inhibitors (SSRIs) were
developed, the first being fluoxetine (Prozac) [Julien et al. 2011]. Newer drugs have only
altered side effects and improvements are still needed in the following ways: (1) superior

22

efficacy (2) faster onset of action (3) improved side effect profile (Julien et al. 2011). It
is most important to understand that antidepressant medications have a variety of side
effects that combined with other medications can be significant or dangerous.
Additionally, the Federal Drug Administration (FDA) has approved specific drugs for
specific purposes and clinicians should be fully aware of their impact on patients along
with recommended dosages. The following drugs are approved by the FDA for the
treatment of MDD: (1) SSRIs (a) fluoxetine [20-60mg/day] (b) sertraline [50-200
mg/day] (c) paroxetine [20-60 mg/day] (d) citalopram [20-60 mg/day] (e) escitalopram
[10-20 mg/day] (2) SSNRI (a) duloxetine [60-120 day] (b) venlafaxine [75-375 mg/day]
(c) mirtazepine [15-45 mg/day] (d) desvenlafaxine [50 mg/day] (3) NDRI (a) bupropion
[300-450 mg/day]. The “mg/day” were recommendations made from the APA practice
guidelines; combined with the FDA approved antidepressant listing.

The practice

guidelines from the APA (2010) also provides a detailed listing of side effects and the
numerous antidepressants associated with that particular side effect and treatment of each
specific side effect.

Lastly, elderly patients are particularly prone to orthostatic

hypotension and cholinergic blockade; for this reason, SSRIs, SNRIs, and other
antidepressants should be considered over MAOIs or TCAs (APA 2010); chronic
conditions in the elderly typically include the need to closely manage comorbid and
treatment conditions involving both physical and psychological drug interactions.
2.6 QUALITY STANDARDS IN EVALUATION, TREATMENT AND REFERRAL
This dissertation attempts to make a clear distinction between the current
practices of mental health diagnoses and those described as a “standard of care” within
the DSM-IV and the practice guidelines (2010) outlined by the APA. Within each
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assessment previously evaluated, each instrument identified that the DSM-IV standards
were the overall “standard of care” prescribed by the APA and others alike and act as if
the overall consensus on evaluations for treatment and referral. Within the health care
system, a referral is commonly known as “needed” if the health provider or practitioner is
uncertain as to what form of treatment is needed to protect both the patient from harm
(malfeasance) and for the provider to not administer something that is not clinically
known to add benefit to the patient (beneficence).
Both the AAFP (2012) and the APA (2010) guidelines suggest the clinician
administer some form of an accepted assessment in order to validate the diagnosis. This
dissertation questions the validity of such assessments and their instrumentation towards
diagnosis and its impact on the patient if psychopharmacology and prescriptive services
are needed. Kessler also expressed concerns later justified with the CIDI results (2007)
within the ESEMeD sample population (Section 2.7). The following are the treatment
recommendations by the APA (psychiatrist management) with regards to MDD: (1)
establish and maintain a therapeutic alliance [assuming this would include a clinically
competent referral network based on the DSM-IV and differential diagnosis
requirements] (2) complete the psychiatric assessment [important that differential
diagnosis and cognition of comorbid and drug interaction effects] (3) establish the
appropriate setting for treatment (5) evaluate functional impairment and quality of life (6)
coordinate the patient’s care with other clinicians (7) monitor the patient’s psychiatric
status (8) integrate measurements into psychiatric management [review of side effects
and therapeutic benefits] (9) enhance treatment adherence [suggestion to monitor clinical
adherence to the DSM-IV standards and differential diagnosis] (10) provide education to
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the patient and the family [suggest clinical education as well]. Below are the treatment
recommendations by the APA (acute phase) with regards to MDD: (1) chose an initial
treatment modality (a) pharmacotherapy (b) other somatic therapies (electroconvulsive
therapy) [ECT] (c) psychotherapy (d) psychotherapy plus antidepressant medication (2)
assessing the adequacy of treatment response (3) strategies to address nonresponse. The
final treatment phases of recommendation for evaluation and monitoring are the
continuation phase, maintenance phase, discontinuation of treatment. The APA
recommendations also outline details regarding the clinical factors influencing treatment
as follows: (1) psychiatric factors [types of psychotropic medication and dosage], (2)
demographic and psychosocial factors [Andersen/House blended framework], and (3) cooccurring general medical conditions (APA 2010).
2.7 PRIMARY CARE PHYSICIANS’ ROLE IN MDD
The details regarding the holistic treatment (physical/mental) is a complex one for
each of the providers, practitioners, and clinician selected to work together towards the
overall health of a patient. Moreover, the task of managing those with chronic and
comorbid conditions/multiple modalities of treatment is even more challenging for all
involved. The primary care physician (PCP) is often the gatekeeper to their patient’s care
and often is found to be the care provider even in complex circumstances of treatment
those with mental illnesses. During the CIDI review of the ESEMeD (2007), only the
following proportions of those surveyed (N=514) were receiving adequate treatment by
severity of MDD: (1) mild [12 percent], (2) Moderate [16 percent], (3) Severe [26
percent], (4) Very Severe [39 percent] (5) Total [22 percent] (Kessler 2007). Within the
Psychological Problems in General Health Care (PPGHC) [primary care], 17 percent had
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depression; within the ESEMeD population sampled, 13.4 percent had major depression
in primary care (Tylee et al. 2007). The PPGHC recognized that 49 percent of those
identified being recognized by the assessment tool criteria as having MDD we not
recognized by their primary care provider (PCP) [Tylee et al. 2007]. The ESEMed
identified that 15 percent with mood disorders and 23 percent with anxiety disorders
(within previous 12 months of a visit to their PCP) did not receive either psychotropic
medications or psychological treatment (Tylee et al. 2007). Either collaborative care or
further extensive training has worked to improve both appropriate diagnosis and
recognition of mental health conditions in the primary care setting (Tylee et al. 2007). In
two studies, the National de la Sante et de la Recaerche Medicale (INSERM] (26,422
PCPs), and the ESEMed review, only 54 percent and 58 percent respectively, of those
meeting the criteria of MDD were considered “psychiatric cases” and only 15 percent and
26 percent respectively received a diagnosis of MDD (Lucrubier 2007). It is important to
note that 63 percent of patients with mood disorders and 79 percent of patients with
anxiety disorders did not seek help over the previous 12 months from their PCP
(ESEMed) [Nutt et al. 2007].
2.8 THEORETICAL FRAMEWORK
2.8.1 FOUNDATIONAL ELEMENTS OF THE FRAMEWORK
A review of several reports/documents was conducted in determining the best
overall theoretical framework considering the integration of behavioral and mental health
services with the current physiological standards of care. The purpose of this section of
the dissertation is to outline the reports/documents reviewed chronologically while
establishing a precedent for integrative care. Integrative care will be defined as the
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collaborative care standard consisting of the combination of the following types of care
and the most optimal referral of such care as determined by both the primary care
physician and the patient: behavioral, mental, spiritual, and physiological.
The first portion of this review will come from a health services policy creation
vantage point, reviewing both the policies of interest concerning integrative care and
those most related to the NESARC dataset utilized in the dissertation research. The
purpose of this section is to demonstrate that the U.S. makes a major shift in policy
implications regarding integrative health policy and its’ intended national practices
towards combining mental health as a standard treatment, evaluation, and practice of care
in the primary setting. It will also demonstrate its prevalence in prevention services as
well as a “national call” towards equity in treatment and payment methods which impact
accessibility of treatment.
Policy evolution regarding mental health care:
In 1996, the “Mental Health Parity Act” (MHPA) was established, intending to
create equality and accessibility (parity) towards treatment for those with mental health
issues (Department of Labor, Fact Sheet on MHPA 1996). The law also established that
financial concerns (insurance) would treat reimbursement for such mental health services
in an equivalent manner to that of physical health. In 1999, the U.S. Surgeon General
established a report entitled, “Mental Health, A Report of the Surgeon General”, which
outlines the national level concerns of mental health in the U.S. and its impact to both the
population as well as its financial impacts and trends towards overall financial burden to
the population. The collaborative care model (CCM) was then outlined as a national
standard of care (2002). Additionally, in 2002, the Substance Abuse and Mental Health
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Services Administration (SAMHSA) published a report to identifying the comorbid
correlation between substance abuse disorders and mental health disorders.
In 2003, the President of the U.S. established a Commission on Mental Health
which published a report called, “Achieving the Promise: Transforming Mental Health
Care in America”. This report outlined specific administrative goals which it hoped to
achieve while outlining particular steps towards achieving such mental health goals. The
President’s report outlined the need for “better coordination between mental health and
primary health care”, calling for the “treatment for co-occurring disorder to be
integrated” and to “expand screening and collaborative care in primary care settings”.
The report also recognized the finding from the World Health Organization (WHO)
which identified mental illnesses as the leading causes of disability worldwide.
In 2008, the “Mental Health Parity and Addiction Equity Act” (MHPAEA) was
passed to limit insurance companies from establishing excessive deductibles, copays, and
coinsurance in order to exclude mental health services in practice and ensure elements of
coverage were covered, more specifically, to include addiction services (Department of
Labor, Fact Sheet on MHPAEA 2008). In 2011, the “National Prevention Strategy” for
public health and health services was authored by the U.S. Surgeon General outlining a
specified framework inclusive of integrative care and strategies to improve overall health
care services (HHS, National Prevention Strategy 2011). Lastly, in 2012, a “Report to
Congress” regarding the “Compliance with MHPAEA” was conducted to assure
policymakers that adherence was being given to the law and its added elements from the
MHPA (1996).
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Although policy concerns were addressed, practical applications to the
implementation of collaborative and integrative care were also being established. In
1967, the American Academy of Pediatrics (AAP) established the first “medical home”
model featured around children and those children with “special needs”, later adding
elements to the “medical home” concept to include all medical services (2002). In 2007,
the “Joint Principles” of the patient-centered medical home (PCMH) were established by
a joint venture lead by AAP, the American College of Physicians (ACP), the American
Osteopathic Association (AOA) and the American Academy of Family Physicians
(AAFP) [AAP 2007]. They would include the following principles related to the overall
care of patients and their health care needs: (1) personal physician (2) physician directed
medical practice (3) whole person orientation (4) coordinated/integrated (5)
quality/safety. Integrative care will be the primary focus regarding the establishment of a
synthesized conceptual framework between all levels of care.
In 2008, a study including the concept of the “Triple Aim”, made up of the
following goals [(1) better care, (2) better health (3) reduced costs] identified that 30% or
$700 billion of health services were “unnecessary” and further categorized these services
as “wasteful” (Berwick, D. M., Thomas, T. W., & Whittington, T. 2008). Berwick’s
outline of the “Triple Aim” added another perspective that “better care” would include
both collaborative and integrative health services in order to “reduce costs” while adding
the elements of “better care” for the population being served. The “Triple Aim” then
synthesized its findings with the PCMH model further stimulating the call for
“Accountable Care Organizations” (ACOs) to produce organizations that (1) increase
quality through per capita primary care cost monitoring over a continuum of care (2)
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payments linked to quality improvement (3) more sophisticated performance
measurement (McClellan M., et al. 2010). ACOs were formally established in 2006 and
took national precedence in 2010, as it became a part of the national health care law, the
Patient Protection and Affordable Care Act (ACA).
Theories relevant to mental health and mental health care:
The following is the primary review regarding the theorized conceptual
framework and its originations. In 1943, Abraham Maslow developed “Maslow’s
Hierarchy of Needs” and published his explanation of human motivation within five
categorical areas: (1) physiological [food, water, shelter, and warmth], (2) safety
[security, stability, freedom from fear], (3) belonging – love [friends, family, spouse,
lover], (4) self-esteem [achievement, mastery, recognition, respect], and (5) selfactualization [pursue inner talent, creativity, fulfillment] (Maslow 1943). This was a
sentinel article within the areas of behavioral and psychological behavior, adding initial
framework depth to the development of human motivation and choices concerning
integrative health. In 2011, the Surgeon General’s office published a report called the
“National Prevention Strategy” (NPS), outlining key strategies going forward in
addressing the public health concerns. Collectively, the identified areas within the NPS
were categorized into the following groups (Figure 2.1): (1) health disparities (2) safe
environment (3) preventive services (4) empowered people (5) integrative mental and
behavioral health. Figure 2.1 (next page) depicts an inverse inter-relationship between
Maslow’s “Hierarchy of Needs” (1943) and its impact concerning the elements within the
NPS (2011). The purpose of Figure 2.1 is to demonstrate a “connection” between
previously established psychological and behavioral models (Maslow 1943) and current
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prevention strategies and/or the national prevention strategies of the nation (NPS 2011).
Within the model, “optimal health” is associated with “self-actualization” (Maslow 1943)
and “integrative mental and behavioral health” (NPS 2011). “Co-morbid and chronic
conditions” are associated with “physiological” elements [such as breathing, food, water,
excretion] (Maslow 1943) and with “health disparities” in the NPS. The model suggests
an improved level of physiological care could exist between “preventive services” and
“health disparities” (NPS 2011) while the established of physiological care between the
two categories suggests an increase in quality and “patient safety” (Figure 2.1).
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Figure 2.1 Maslow’s Hierarchy of Needs (1943) Comparison Surgeon General’s National Prevention Strategy (2011)
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Note: “Patient Safety” becomes the link between Maslow’s Hierarchy of Needs (1943) and Surgeon General’s National
Prevention Strategy (2011) when Integrative Health Framewo
Frameworks are evaluated and compare

In 1969, Elisabeth Kubler-Ross developed another psychological and behavioral
pivotal theory called, “The Five Stages of Death/Grief”. The rationale for the evaluation
of this theory, like Maslow’s, “Hierarchy of Needs”, is two-fold: (1) established as a
sentinel finding in the field of psychology and behavioral theory (2) indicates an
established leveling of “health” comparative to psychological elements such as “coping”.
Additionally, unlike Maslow’s “Hierarchy of Needs”, Kubler-Ross addresses elements of
“death/grief” which are more centralized to the aging population. A review of both the
best practices in death/grieving “coping” and the overall improved (optimal) health status
of the aging population would seem relevant, as one attempts to frame the correlations
between mental/behavioral health and physiological elements of health in what national
policy seems to demand in collaborative and integrative health. These finding were
previously discussed and demonstrated to be valid with the review in policy to include,
but is not limited to, the following: CCM, Triple Aim PCMH, and ACOs.
Kubler-Ross identifies “The Five Stages of Grief” from beginning to end as such:
(1) Denial (2) Anger (3) Bargaining (4) Depression (5) Acceptance [Figure 2.2]. The
process begins with the concept of “coping” through a period of time in “denial” of the
event itself. Experience regarding the frequency of death and loss and the preparation for
the event (trauma) seem to be most likely experientially impacted by the age of the
person involved. The more time it takes to navigate through the “five stages” the more
likely the person impacted will experience an increase in comorbid or chronic elements
of mental health. Inclusively, as one “travels” through the five periods, experience by
experience, the “build up” of one event, toppled upon another, would also increase the
likelihood of comorbid chronic mental health resulting from multi-level experiences of
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both unexpected/expectant death through multiple unresolved grief-based events.
Likewise, the reciprocal version of “The Five Stages of Grief” can be experienced by the
recently created, “Transitional Self Actualization of Healthy Aging” (2013), in which the
impact of health on the aging population can be viewed quite differently regarding their
“transitional” ability to “cope” with death and loss. First, seniors are more used to
experiencing death and loss of their friends and close family members, so as their
experiences “normalize” (more aware) [Figure 2.2, next page], the quicker they adapt to
the initial stages (given their shortened comparative period of mortality) of “The Five
Stages of Grief”, the most optimal health they can have for the finite time period of life
remaining. Additionally, the expeditious movement through the five stages would seem
to product a decrease in comorbid or chronic mental health conditions. As one ages, it
would appear that the reciprocal elements of the five stages would be dependent on
“awareness” and “normative” responses to the aging processes and the decisions being
made through the processes of aging.
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Figure 2.2 Kubler-Ross Stages of Grief/Death and Unexpected Illness / Transitional Self Actualization for Healthy Aging
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2.8.2 FRAMING THE FRAMEWORK (ANDERSEN AND HOUSE)
Abraham Maslow (1943) and Elisabeth Kubler-Ross (1969) framed the
psychological and behavioral rationale behind a need for the collaborative and integrative
(blended) framework in primary care and preventive health delivery, even if that was not
their initial intentions when developing their theories. Figure 2.1 demonstrated the need
for integrative mental and behavioral health in modern day medical treatment, given the
inverse relationship between Maslow and NPS while Figure 2.2 demonstrated another
inverse mental and behavioral health relationship as it related to the aging process, in
Kubler-Ross and the “Transitional Self Actualization in Healthy Aging” model. The
term “Self Actualization” was attributed to the model established by Abraham Maslow
and his final stage of human motivation.
Ronald Andersen (1995) and James House (1981, 2001) were the two theoretical
frameworks selected to “blend” both a “health services” model (Andersen 1995) [Figure
2.3] and a social/behavioral model (House 1981 & 2001) [Figures 2.4 & Figures 2.5].
Andersen’s model focused on four categorical areas in his identification of health
services utilization: (1) Environment (2) Population Characteristics (3) Health Behavior
(4) Outcomes (Andersen, 1995). Under the “environment” category, two subcategories
emerged: (1) health care system (2) external environment. The “population characteristics”
consisted of the following three subcategories: (1) predisposing characteristics (2) enabling
resources (3) need. The “health behavior” category was made up of the following two
subcategories: (1) personal health practices (2) use of health services. Lastly, the
“outcomes” category consisted of the following three subcategories: (1) perceived health
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status (2) evaluated health status (3) consumer satisfaction (Andersen, 1995) [Figure 2.3].
House’s, “Paradigm of Stress Research” (1981)
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Figure
igure 2.3 Andersen’s Health Services Conceptual Framework Model (1995)
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Figure 2.4 House’s Conceptual Framework: Paradigm of Stress Research (1981)
CONDITIONING VARIABLES: Individual or Situational
(e.g., social support)
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SHORT-TERM
RESPONSES TO STRESS
1. Physiological
2. Cognitive/Affective
3. Behavioral
(de
fen
ses
)

(coping)

STRESSORS: Objective
Social Conditions
Conductive to Stress

PERCEIVED
STRESS

ENDURING
HEALTH OUTCOMES
1. Physiological
2. Cognitive/Affective
3. Behavioral

Note: Solid arrows between boxes indicate presumed casual relationships among variables. Lighter arrows from the box labeled
“conditioning variables” intersect solid arrows, indicating an interaction between the conditioning variables in the box at the
beginning of the solid arrow in predicting variables in the box at the head of the solid arrow as published in House (1981:36).

Figure 2.5 House’s Conceptual Framework for Understanding Social Inequities in Health and Aging (2001)
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[Figure 2.4] may focus on “stress”, however, the blended framework with utilize
his thorough flowchart review of both individual and situational conditioning variables
and their relationship to overall “health” versus “stress”. Our research would suggest a
correlational assumption that overall “stress” accounts for a similar relational response to
the overall “health” of an individual. The key conceptual components considered within
House’s model (1981) to create our blended framework are the following: (1)
conditioning variables, both individual and situational, have an impact on objective social
conditions impacting overall health (2) both perceived and objective (evaluated) events
both positive and negative impact short-term level responses to health (3) coping and
defense mechanisms relative to both objective and perceived events have an impact on
both short-term response mechanisms and long-term health outcomes (4) short-term
responses and long-term elements consider of the following subcategorical elements of
health: physiological, cognitive/affective, and behavioral (House, 1981) [Figure 2.4].
Additionally, House’s (2001) [Figure 2.5] further contribution to the blended framework
comes within the following three areas of original contribution: (1) the identification of
specific explanatory variables accounting for psychosocial risk factors such as: health
behaviors, social relationships/support, chronic/acute stress, psychological dispositions
and social roles/productive activities (2) an increased focus of definitive subcategories of
health outcome to include the following: mortality, institutionalization, morbidity
(chronic), functional limitations, self-rated health, cognitive function, and depression (3)
the inclusion of physical/chemical and social environmental hazards (House 2001).
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2.8.3 FINAL BLENDED FRAMEWORK (ANDERSEN AND HOUSE)
The final blended framework [Figure 2.6, next page] centers on the Andersen’s (1995)
formation of categorization (environment, population characteristics, health behavior, and
outcomes), however, expands them into a more comprehensive and integrative heading
consisting of the following: (environment, individual/situational characteristics [House
1981], short-term health behaviors [House 1981 & Andersen 1995], enduring health
outcome [House 1981 & Andersen 1995]. The category labeled “environment”
maintained Andersen’s original two categories (health care system and external
environment), however, the following subcategories were added: (1) under health care
system (a) access to medical care (b) insurance status (c) enabled resources (2) under
external environment (a) physical/chemical, social and environmental hazard (House
2001). “Enabled resources” were originally sectioned as a subcategory under Andersen’s
category of “population characteristics” (Figure 2.3), however, given its importance to
the blended model, “enabled resources” was placed as a subcategory of consideration
earlier in the blended model under the category of the “health care system” (Andersen
1995). In “enabled resources” previous place, “psychosocial risk factors” were
considered to be the psychological and behavioral element most needed, as it was
referenced as important by House in 2001. The elements under “psychosocial risk
factors” (health behaviors, social relationships/support, chronic/acute stress,
psychological dispositions, and social roles/productive activities) add needed depth to the
model attempting to create a most collaborative and integrative model of health to
include health services research and psychological and behavioral health (House 2001).
Andersen’s model then has a subcategory of “need” under “population characteristics”.
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This appeared to be quite broad so the blended model depicted “need” as
“perceived/evaluated health need”, focusing on physiological need, since “psychosocial
risk factors” would address the psychological, behavioral, and mental health conditions
and status (Figure 2.6).
Andersen’s previously listed category, “health behavior”, was utilized, however,
given the collaborative and integrated intention of the blended framework, adjusted to
“short-term health behavior” (Figure 2.6). Andersen’s subcategory of “personal health
practices” was comprehensively altered to “decisional / personal health practices”,
ensuring the inclusion of decision-making and choice reflecting back to address both the
perception of needed health services. The next subcategory was entitled, “stressors:
objective biopsychosocial conditions conducive to diminishing health” given its account
for the elements associated with the “biopsychosocial” areas of health (House 1981).
Figure 2.6 depicts the present and short-term health inner-relationships between three
areas: (1) perceived/evaluated health need (2) decisional/personal health practices (3)
stressors: objective biopsychosocial conditions conducive to diminishing health. This
circular relationship would indicate that the “need” is more than the utilization of health
services but the preventative understanding (awareness) of multi-faceted conditions
(social, physiological psychological, biological, behavioral, mental, etc…) and a timely
response to addressing the collective of those needs (Figure 2.6). Much of this is due to
the perceived and evaluated health from multiple sources characterized by the categorical
heading of “individual and situational characteristics”. It is vitally important for both the
individual and the health professional to comprehend, understand, and address these
multi-faceted health concerns in a comprehensively, communicated, collaborative, and
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Figure 2.6 Andersen (1995) / House’s ((1981,
1981, 2001) Blended Conceptual Framework Model
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integrated way to prevent short-term and long-term negative health outcomes
and/or comorbid/chronic health conditions.
“Perceived / Evaluated Health Need” is a subcategory of both the “short-term
health behavior” category as well as the final category, the “enduring health outcome”
category developed through an influence by House (1981). The continuation of
“perceived /evaluated health need” demonstrates the short-term to long-term anticipated
decline in health outcome if the “need” is not perceived by the individual and evaluated
by the collective of health professionals. The final category under “enduring health
outcome” is “actual health” with multiple sub-components taken from both House (1981)
and Andersen (1995): (1) physiological (2) cognitive/affective (3) behavioral (4)
consumer/patient satisfaction [Figure 2.6].
Most importantly, health is outlined as the integration of elements 1-4 and a
pathway is drawn best describing prevention and wellness around the awareness of
“actual health”. When categories of “environment” and “individual and situational
characteristics” are collectively understood, the individual can reduce the elements
impacting their “actual health”. The model seems to also demonstrate the timely
dependence on self and health professionals to identify the “perceived/evaluated need”.
As Andersen projects in his health services research model, the discovery of
“perceived/evaluated need” can explain the gaps between access, quality, and value in
health services utilization while House’s contributions can preventatively demonstrate the
“need” for social, psychological, and behavioral impacts to include physiological
utilization of health services and link “awareness” to both the individuals seeking care
and the professionals delivering such care (Figure 2.6).
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Arthritis (independent variable of interest) is more physiological and seems more
appropriately represented by a medical model approach. Regarding arthritis, Andersen’s
(1995) Health Services Model was selected for review, given its collective account for
the following categories: health care system, external environment, population
characteristics, health behavior, and outcomes focus. However, with concerns to overall
“outcome”, it would seem that of the three subcategories, (perceived health status,
evaluated health status, and consumer satisfaction) there were psychological elements
within an integrated methodology that is needed to fully account for overall health
outcome in the model.
House’s (1981 & 2001) models account for the psychological elements
(psychosocial risk factors) and appeared more comprehensive. MDD (dependent
variable) is a psychological disorder for which an appropriate model must be considered.
The blending of both a physiological, health services model (Andersen 1995) and a
psychological/behavioral model for which House demonstrated creates a blended
framework which both match current health policy initiatives and
collaborative/integrative health care initiatives. Additionally, the blended framework and
model will add value in explaining the inter-relationship between those with depression
and the arthritic condition.
2.9 CHARACTERISTICS OF THE POPULATION AGED 65 AND OLDER
This portion of the dissertation will focus on an overall demographic description
of the older population (to include spending), as well as describing key identified
descriptive variables to include the following: “age”, “gender” and “health status”.
Focus on “spending” and its relationship to the blended framework:
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It is important to focus on several Medicare cross-sectional analyses of “cost”,
given the selected blended framework (Andersen/House) and the inclusion of
“mutability” (Andersen, 1995). Previously, the health policy trends were outlined to
describe concepts such as “the Triple Aim” (population health, per capita costs, and the
experience of care), “PCMH” and “ACOs”. Additionally, the push for collaborative and
integrative care models (including behavioral health) impacts the overall medical home
model, as providers seek to increase services while decreasing costs associated with
untreated, mistreated, or non-treatment. This is particularly true with the chronic care
model and conditions which are most prevalent in this particular population. As the
“Triple Aim” suggests, population health must account for “quality” (right treatment, at
the right cost, at the right time) in order to optimize the “health outcome” while
minimizing the overall societal impact (scarcity and limited amount of health resources).
Andersen’s model regarding utilization and health services suggest that “cost” be
considered first (preventative) under the “health care system” in which “access” provides
a level of preventative care suggesting that proactive accounts for “cost” become not only
imperative in current health policy affairs but vital and could even account for many
“patient safety” issues (Figure 2.1). If a descriptive account of “cost” by “condition” or
other primary subset (gender, age, etc…) can provide both preventative (mutable)
strategies for intervention and/or new and improved methods of assessment (early
detection) and treatment, now is the time for “cost containment” measures to
implemented in an effort to redirect health resources while optimizing health outcomes.
Grouping the older population (most costly group/per capita) and crosssectionalizing them by categories is a necessary element for discovery aligned with
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intervention strategies towards health improvement. Within the blended framework, the
focus on both the “perceived” and “evaluated” health of someone more likely to be
suffering from “depression” (psychological condition) while having “arthritis”
(physiological condition) both suggests the importance of the integrated care model
(prevent chronic/costly conditions) while demonstrating that “perceived” health is
potentially a “call” for required “assessment tools” for those displaying particular
psychological and physical responses/characteristics in the primary healthcare setting.
Medicare Demographics and Spending:
The following information was derived from the CMS National Health
Expenditure (NHE) report (2011). The elderly population consisted of more than 42
million persons over the age of 65. The per capita spending per enrollee (2011) was
$10,900 for which the national budget for Medicare was $554 billion. $231 billion were
consumed by hospitals (in-patient services), $124 billion were utilized for
physician/clinical services, and nearly $64 billion were spent on prescription drugs.
Additionally, the overall budget for Medicaid during this period was $407 billion given
that over 5 million seniors are dual eligible (utilize both Medicare/Medicaid) [CMS,
National Health Expenditures 2011].
Age: (Subcategories of 65-74, 75-84, and 85+):
According to the US Census (2010), there are over 40 million persons in the US
aged 65 and over. Of those, over 21 million persons were between the ages of 65-74
(youngest old), 13 million were between the ages of 75-84 (middle old), and 5.5 million
were of an age greater than 85 years (US Census 2011). Between the periods of 2000 –
2010, the US population grew by 27 million persons, those 65 and older grew by 5.2
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million during that period (US Census 2011). During this same period, those categorized
as the youngest old grew by 3.3 million person, those middle old persons grew by 700,
000 persons, and the oldest old grew by 1.2 million persons (US Census 2011).
Gender/Age: (Subcategories of 65-74, 75-84, and 85+):
The total population of males in the US over 65 years in 2010 was 17.3 million
persons, a 3 million person increase over that in 2000 (US Census 2011). Of those, 10
million were 65-74 (1.8 million increase), 5.5 million were 75-84 (600,000 person
increase), and 1.8 million were over 85 years of age; a 550,000 person increase from
2000 (US Census 2011).
The total population of females over 65 years of age in 2010 was 22.9 million, a
2.3 million person increase over 2000 (US Census 2011). Those women in the age group
of 65-74 (in 2010) was 11.6 million (increase of 1.5 million persons), the number of
women between 75-84 was 7.6 million (100, 000 increase), and 85+ women numbered
3.7 million (700,000 increase) [US Census 2011).
Health Status (Respondent Reported) by Age [65-74, 75-84, and 85+]:
The following statistical information regarding health status and age
categorization was provided by the CDC’s “Health Data Interactive” with sourcing
information retrieved from the longitudinal collection (1997-2011) of the National Health
Interview Survey (NHIS).
Of those older persons 65-74, nearly 42 percent reported having “excellent/very
good” health, 34 percent had “good” health, however, nearly 21 percent of those 65-74
report “fair/poor” health. Seniors in the age group of 75-85 have the following selfreported health status: 38 percent have an “excellent/very good” health status, 35 percent
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report having “good” health, while 27 percent disclose having “fair/poor” health. Lastly,
those persons 85+ self-report the following: 30 percent have “excellent/very good”
health, 36 percent report having “good” health, while 34 percent disclose having
“fair/poor” health.
2.10 CHRONIC CONDITIONS OF THE US POPULATION
AGED 65 AND OLDER
Nationally:
Elderly beneficiaries, 65-74, are most likely to experience the following chronic
conditions: 52 percent will have hypertension, 47 percent will also have hyperlipidemia,
27 percent will have diabetes, 26 percent will have heart disease, 27 percent will have
diabetes, 25 percent will have RA, 11 percent will have depression and 5 percent will
have OA (CMS Chronic Conditions Dashboard 2011). Additionally, those seniors, 7584, will experience the following prevalence rates a chronic effects: 66 percent will have
hypertension, 53 percent will have hyperlipidemia, 38 percent will have heart disease, 34
percent will suffer from RA, 30 percent will have diabetes, 12 percent will have
depression, and 9 percent will have OA (CMS Chronic Conditions Dashboard 2011).
Lastly, for those 85+, the following prevalence rates and chronic medical issues will
occur: 70 percent will have hypertension, 43 percent will have heart disease, 42 percent
will have hyperlipidemia, 39 percent will have RA, 16 percent will depression, and 13
percent will have OA (CMS Chronic Conditions Dashboard 2011).
By Age, Gender, and Type (All/Dual/Non-Dual):
Per the remainder of the dissertation, “dual” will be defined as having both
Medicare and Medicaid insurance while Non-Dual is in reference to those only having
Medicare as their primary form of insurance. This will be categorized by the following:
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dual, non-dual, and “all” (a combination of dual/non-dual). The population of elderly
Americans is about 43 million, with approximately 9 million (25 percent) being dual
eligible and 36 remaining solely provided for under Medicare (US Census 2010).
Elderly female beneficiaries (all), 65-74, are most likely to experience the
following chronic conditions: 57 percent will have hypertension, 45 percent will also
have hyperlipidemia, 26 percent will have diabetes, 29 percent will have heart disease, 26
percent will have diabetes, 29 percent will have RA, 15 percent will have depression, 15
percent chronic kidney disease and 7 percent will have OA (CMS Chronic Conditions
Dashboard 2011). Comparatively, elderly male beneficiaries (all), 65-74, are most likely
to experience the following chronic conditions: 51 percent will have hypertension, 46
percent will also have hyperlipidemia, 29 percent will have diabetes, 32 percent will have
heart disease, 26 percent will have diabetes, 20 percent will have RA, 7 percent will have
depression, 12 percent chronic kidney disease and 1 percent will have OA (CMS Chronic
Conditions Dashboard 2011).

This same group of female beneficiaries (dual) are most

likely to experience these heightened rates of chronic disease prevalence: 70 percent will
have hypertension, 52 percent will also have hyperlipidemia, 45 percent will have
diabetes, 34 percent will have heart disease, 26 percent will have diabetes, 40 percent will
have RA, 25 percent will have depression, 19 percent chronic kidney disease and 11
percent will have OA (CMS Chronic Conditions Dashboard 2011). This same group of
male beneficiaries (dual) are most likely to experience these heightened rates of chronic
disease prevalence: 63 percent will have hypertension, 45 percent will also have
hyperlipidemia, 45 percent will have diabetes, 40 percent will have heart disease, 26
percent will have diabetes, 26 percent will have RA, 16 percent will have depression, 22
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percent chronic kidney disease and 2 percent will have OA (CMS Chronic Conditions
Dashboard 2011).

Within this same group of younger old (65-74) women (non-dual),

they are most likely to experience the following chronic conditions: 51 percent will have
hypertension, 47 percent will also have hyperlipidemia, 22 percent will have diabetes, 18
percent will have heart disease, 26 percent will have diabetes, 28 percent will have RA,
12 percent will have depression, 8 percent chronic kidney disease and 8 percent will have
OA (CMS Chronic Conditions Dashboard 2011). Within the same group of younger old
(65-74) male (non-dual), they are most likely to experience the following chronic
conditions: 49 percent will have hypertension, 46 percent will also have hyperlipidemia,
27 percent will have diabetes, 31 percent will have heart disease, 26 percent will have
diabetes, 19 percent will have RA, 6 percent will have depression, 11 percent chronic
kidney disease and 1 percent will have OA (CMS Chronic Conditions Dashboard 2011).
The middle oldest group (all) of females (74-85) are most likely to experience the
following chronic conditions: 68 percent will have hypertension, 53 percent will also
have hyperlipidemia, 26 percent will have diabetes, 32 percent will have heart disease, 29
percent will have diabetes, 39 percent will have RA, 15 percent will have depression, 16
percent chronic kidney disease and 14 percent will have OA (CMS Chronic Conditions
Dashboard 2011). The middle oldest group (all) of males (74-85) are most likely to
experience the following chronic conditions: 62 percent will have hypertension, 53
percent will also have hyperlipidemia, 33 percent will have diabetes, 46 percent will have
heart disease, 29 percent will have diabetes, 27 percent will have RA, 9 percent will have
depression, 21 percent chronic kidney disease and 2 percent will have OA (CMS Chronic
Conditions Dashboard 2011). The “dual” group of middle-oldest women presented with
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the following chronic conditions: are most likely to experience the following chronic
conditions: 78 percent will have hypertension, 52 percent will also have hyperlipidemia,
45 percent will have diabetes, 43 percent will have heart disease, 26 percent will have
diabetes, 46 percent will have RA, 24 percent will have depression, 25 percent chronic
kidney disease and 15 percent will have OA (CMS Chronic Conditions Dashboard 2011).
The “dual” group of middle-oldest men presented with the following chronic conditions:
70 percent will have hypertension, 47 percent will also have hyperlipidemia, 45 percent
will have diabetes, 49 percent will have heart disease, 43 percent will have diabetes, 32
percent will have RA, 18 percent will have depression, 30 percent chronic kidney disease
and 4 percent will have OA (CMS Chronic Conditions Dashboard 2011). The “non-dual”
group of 75-84 women, presented with the following conditions: are most likely to
experience the following chronic conditions: 66 percent will have hypertension, 53
percent will also have hyperlipidemia, 26 percent will have diabetes, 29 percent will have
heart disease, 25 percent will have diabetes, 37 percent will have RA, 13 percent will
have depression, 14 percent chronic kidney disease and 13 percent will have OA (CMS
Chronic Conditions Dashboard 2011). The “non-dual” group of 75-84 men, presented
with the following conditions: 61 percent will have hypertension, 53 percent will also
have hyperlipidemia, 26 percent will have diabetes, 46 percent will have heart disease, 31
percent will have diabetes, 27 percent will have RA, 7 percent will have depression, 20
percent chronic kidney disease and 2 percent will have OA (CMS Chronic Conditions
Dashboard 2011).
The oldest age women (85+) [all] had these chronic conditions: 73 percent will
have hypertension, 41 percent will also have hyperlipidemia, 26 percent will have
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diabetes, 39 percent will have heart disease, 25 percent will have diabetes, 43 percent will
have RA, 18 percent will have depression, 23 percent chronic kidney disease and 17
percent will have OA (CMS Chronic Conditions Dashboard 2011). The oldest age men
(85+) [all] had these chronic conditions: 66 percent will have hypertension, 45 percent
will also have hyperlipidemia, 29 percent will have diabetes, 53 percent will have heart
disease, 25 percent will have diabetes, 31 percent will have RA, 12 percent will have
depression, 31 percent chronic kidney disease and 4 percent will have OA (CMS Chronic
Conditions Dashboard 2011). Those 85+ women who were considered dual also had
these listed conditions: 77 percent will have hypertension, 37 percent will also have
hyperlipidemia, 35 percent will have diabetes, 46 percent will have heart disease, 26
percent will have diabetes, 49 percent will have RA, 28 percent will have depression, 29
percent chronic kidney disease and 18 percent will have OA (CMS Chronic Conditions
Dashboard 2011). Those 85+ men who were considered dual also had these listed
conditions: 73 percent will have hypertension, 39 percent will also have hyperlipidemia,
35 percent will have diabetes, 55 percent will have heart disease, 38 percent will have
diabetes, 38 percent will have RA, 23 percent will have depression, 39 percent chronic
kidney disease and 5 percent will have OA (CMS Chronic Conditions Dashboard 2011).
Lastly, those women 85+ considered non-dual also had these diagnosed medical
conditions: 71 percent will have hypertension, 43 percent will also have hyperlipidemia,
22 percent will have diabetes, 36 percent will have heart disease, 26 percent will have
diabetes, 41 percent will have RA, 15 percent will have depression, 21 percent chronic
kidney disease and 17 percent will have OA (CMS Chronic Conditions Dashboard 2011).
Lastly, those men 85+ considered non-dual also had these diagnosed medical conditions:
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65 percent will have hypertension, 46 percent will also have hyperlipidemia, 27 percent
will have diabetes, 29 percent will have heart disease, 26 percent will have diabetes, 31
percent will have RA, 10 percent will have depression, 29 percent chronic kidney disease
and 3 percent will have OA (CMS Chronic Conditions Dashboard 2011).
2.11 COSTS ASSOCIATED WITH THE OLDER POPULATION
Nationally, total members by age 65+ dual enrollment (Medicare/Medicaid) and
non-dual (Medicare only) were accounted for in a cross-sectional analysis (CMS,
Chronic Conditions Dashboard 2011). One limitation of the analysis is that it did not
include an account for “all” members (by age group) to compare between “dual” and
“non-dual” members. Those dual members who had 0-1 chronic conditions cost
$3,023/annually versus non-dual enrollees annual fee of $1,871. Dual members having
2-3 chronic conditions utilized $7,687/annually while non-dual members used $5,202 of
the CMS budget. Dual members having 4-5 chronic issues utilized $14,337/annually
while non-dual members used $10,817/annually. Lastly, dual members with 6+ chronic
conditions utilized $36,047/annually and non-dual members used $29,312/annually.
Those older persons 65-74, having 0-1 chronic issue, the dual member utilized
$1,944/annually while the non-dual used $1,621. Of this group, they represent 33
percent of its members and 7 percent of overall spending with the group. Those older
persons 65-74 with 2-3 chronic issues, the dual member utilizes $5,847/annually while
the non-dual represents $4,712 of annual CMS spending per capita. Of this group, they
represent 31 percent of its members while spending 19 percent of their overall budgetary
costs. Those older persons 65-74 with 4-5 chronic conditions, the dual member utilizes
$12,629/annually while the non-dual represents $10,131/annually. Of this group, they
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represent 22 percent of its members while spending 27 percent of its overall annual
budget. Lastly, of those members 65-74 with 6+ chronic conditions, the dual members
spend $37,236/annually and the non-dual spends $29,176/annually. Of this group, the
6+ chronic conditions members represent 14 percent of the total group, however,
consume 47 percent of all sub-group spending (CMS, Chronic Conditions Dashboard
2011).
Of those older persons 75-84 (0-1 chronic issue), the dual member utilized
$2,084/annually, while the non-dual used $2,103. Of this group, they represent 23
percent of its members and 5 percent of overall spending with the group. Those older
persons 75-84 with 2-3 chronic issues, the dual member utilizes $5,881/annually while
the non-dual represents $5,084 of annual CMS spending per capita. Of this group, they
represent 33 percent of its members while spending 16 percent of their overall budgetary
costs. Those older persons 75-84 with 4-5 chronic conditions, the dual member utilizes
$12,036/annually while the non-dual represents $10,378/annually. Of this group, they
represent 26 percent of its members while spending 27 percent of its overall annual
budget. Lastly, of those members 75-84 with 6+ chronic conditions, the dual members
spend $33,911/annually and the non-dual spends $28,650/annually. Of this group, the
6+ chronic conditions members represent 18 percent of the total group, however,
consume 52 percent of all sub-group spending (CMS Chronic Conditions Dashboard
2011).
Those older persons 85+ having 0-1 chronic issue, the dual member utilized
$3,573/annually while the non-dual used $2,712/annually. Of this group, they represent
17 percent of its members and 4 percent of overall spending with the group. Those older
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persons 85+ with 2-3 chronic issues, the dual member utilizes $7,471/annually while the
non-dual represents $6,101 of annual CMS spending per capita. Of this group, they
represent 29 percent of its members while spending 14 percent of their overall budgetary
costs. Those older persons 85+ with 4-5 chronic conditions, the dual member utilizes
$13,119/annually while the non-dual represents $11,993/annually. Of this group, they
represent 28 percent of its members while spending 26 percent of its overall annual
budget. Lastly, of those members 85+ with 6+ chronic conditions, the dual members
spend $30,547/annually and the non-dual spends $29,293/annually. Of this group, the 6+
chronic conditions members represent 26 percent of the total group, however, consume
57 percent of all sub-group spending (CMS Chronic Conditions Dashboard 2011).
2.12 INTRODUCTION TO DEPRESSION
Depression is an affective disorder, characterized by alterations in emotion or
mood. The diagnosis of “major depressive episode” (MDD) is based on the following
criteria, of which five must be evident daily or almost every day for at least two weeks
(American Psychiatric Association 1994): depressed or irritable mood, decreased interest
in pleasurable activities and in the ability to experience pleasure, significant weight gain
or loss (>5 percent change in a month), insomnia or hypersomnia, psychomotor agitation
or retardation, fatigue or loss of energy, feelings of worthlessness or excessive guilt,
diminished ability to think or concentrate, and recurrent thoughts of death or suicide
(Julien et al. 2011) [Table 3.1].
Of those ages 65+, nearly 5 million persons are reported to have depression
(CMS, Chronic Conditions Warehouse 2010). Depression affects 6 percent to 10 percent
of older adults in primary care settings and 20 percent to 40 percent of those with chronic
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medical conditions (Donahue et al. 2011). In 2000, 9.2 percent of the older population
was receiving some form of treatment for depression; comparatively, 14.3 percent are
receiving treatment in 2010 (CMS). According to the CMS, 15 percent of all persons
over the age of 65 have depression (Chronic Conditions Dashboard 2011). Of those, 18
percent are female and 11 percent are male.
2.12.1 PREVALENCE RATES
Depression is the most common affective or mood disorder of old age. About 15
percent Americans who are 65 years or greater suffer from increased depression, and, of
those, 3 percent to 26 percent are elderly people residing in the community (Cloninger
2002). The prevalence level of depression is higher among the hospitalized elderly of 65
years and over at about 23 percent, and ranges from 16 percent to 30 percent among
nursing home residents. Depression among the elderly can follow a major precipitant
event or loss and is often related to chronic illness or pain (Boslaugh 2010).
Of those 65-74, 11 percent have depression, 6 percent only have depression, 27
percent have 1-2 conditions, 32 percent have 3-4 conditions, and 34 percent have 5+
conditions. Of those 75-84, 12 percent have depression, 2 percent only have depression,
17 percent have 1-2 conditions, 30 percent have 3-4 conditions, and 51 percent have 5+
conditions. Lastly, those 85+, 16 percent have depression, 1 percent only have depression,
13 percent have 1-2 conditions, 29 percent have 3-4 conditions, and 58 percent have 5+
conditions. 14 percent of women 65-74 suffered from depression, 15 percent of women
75-84 also had depression, and 18 percent of women 85+ were diagnosed with depression.
7 percent of men ages 65-74 had depression, 9 percent of men 75-84 suffered from
depression, and 12 percent of men ages 85+ had depression (CMS, Chronic Conditions
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Dashboard 2011).
2.12.2 COSTS OF DEPRESSION
According to a recent study regarding depression in the elderly population, 11.5
percent of this population has depression (Schneider et al. 2009). Of the conditions
measured within the study, the prevalence rate reported was less than only diabetes (24.3
percent) and heart failure (17.7 percent) [Schneider 2009]. Regarding all mental health
conditions, the US spent $73 billion of which $19.6 billion dollars was spending within
Medicare (AHRQ, Medical Expenditure Survey 2010). Additionally, $24.1 billion were
for out-patient services, 15.1 billion were spent on in-patient services and $45.3 billion on
prescriptive medications (AHRQ, Medical Expenditure Survey 2010). The total
expenditures for depression by Medicare (2005) were slightly more than $3.2 billion
dollars and spent nearly $17,000 per year (2005) on those diagnosed seeking treatment
for depression (Schneider 2009). An overall budgetary concern for depression must be
given the population (42 million older persons) [US Census 2010] and the prevalence of
elderly depression (11.5 percent or 4.8 million) and the overall current annual cost
reported by Medicare for per capita treatment ($10,900 per enrollee) [CMS, National
Health Expenditures 2011]; the real projection of cost for depression treatment (point
prevalence) is $50 billion. This realized projection of depression under-treatment to
actual treatment need is 15 times less than of the actualized budgetary commitment of
$3.2 billion. Of the conditions measured within the previous study, the overall per capita
cost for depression treatment was only less than that for chronic kidney disease
($26,671), chronic obstructive pulmonary disease [COPD] ($21,409) and heart failure
($20,525) [Schneider 2009].
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2.13 INTRODUCTION TO ARTHRITIS
AORC is the most common cause of disability in the US (CDC; MMWR 2007).
Arthritis affects 50 million Americans (Murphy et al. 2009) and approximately one in
five adults in the US reported doctor-diagnosed arthritis between the periods of 20072009 (Flegal et al. 2010); 22% of adults in the US population have arthritis (Cheng et al.
2009). By 2030, an estimated 67 million Americans ages 18 years or older are projected
to have doctor-diagnosed arthritis (Hootman & Helmick 2006). Of those ages 65+,
nearly 10 million persons are reported to have RA and 2.3 million to have OA (CMS,
Chronic Conditions Warehouse 2010). In 2030, >50% of arthritis cases will be among
adults older than age 65 years. However, working-age adults (45–64 years) will account
for almost one-third of cases (Hootman & Helmick 2006) Additionally, 25.9% of
women and 18.3% men report doctor-diagnosed arthritis (Hootman & Helmick 2006).
2.13.1 TYPES OF ARTHRITIS
Osteoarthritis (OA), also known as degenerative arthritis or the wear and tear
arthritis is a chronic disease that affects the synovial joints. It affects the joint capsule
containing bone, cartilage and joint fluid. It is a wide spread type of arthritis and
Conservative estimates indicate that in 2005, over 26.9 million adults in the US suffered
osteoarthritis (Lawrence, Felson, & Helmick 2008).
Osteoarthritis targets the smooth cartilage that covers the end of bones to facilitate
significant movement seen in the joint and hip. One is said to be suffering from OA when
this smooth cartilage starts to break down. The disease causes the cartilage to wear off
quicker than the body can repair it leading to bones rubbing on each other hence swelling
and pain and the hyaluronic acid found in the joint is decreased.
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Signs and symptoms of osteoarthritis manifest themselves with time. Joint pain
can be experienced after an activity but goes away with rest; in advancing cases one can
experience pain during rest. This form of arthritis can appear in two forms idiopathic and
secondary forms. Idiopathic osteoarthritis is more prevalent in elderly people and seems
to appear with age and not from a definitive cause. Secondary osteoarthritis is more
prevalent in young adults and can be as a result of trauma to the joint.
There are no definitive ways to prevent osteoarthritis but physicians have given
guidelines to help reduce the progression of the disease through weight loss, aerobic
exercises, using therapy, glucosamine and increased vitamin B5 intake. This form of
arthritis mostly affects the hips, spine and knees. According to Meisser (2005), weight
loss is a must for patients suffering from osteoarthritis as it reduces loads on affected
joints especially in obese and overweight elderly people.
Rheumatoid arthritis (RA) is an autoimmune chronic disease that is characterized
by inflammation of joints and sometimes other body tissues. Autoimmune infections are
as a result of the body’s immune system failing to recognize a body tissue. It then attacks
it as foreign. In rheumatoid arthritis, the body’s immune system targets the synovial
membrane which releases synovial fluid that lubricates the joints. This attack causes the
membrane to inflame, thicken and erode leading to joint deformities. Although the
synovial membrane is the primary target, other surrounding tissues or organs can be
affected by rheumatoid arthritis.
Rheumatoid arthritis is more common in women than men and affects about 1%
of the population. Scientist cannot definitively pin point the cause of autoimmune
conditions like rheumatoid arthritis. Symptoms of rheumatoid arthritis can appear with
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time but are usually prevalent between the ages of 20-60 years. The severity depends on
individuals and the earlier the onset of the disease the more harsh and severe it will be.
Research studies have shown that patients with rheumatoid arthritis are highly prone to
depression.
Confusion can arise as to what form of arthritis one suffers from with the many
symptoms like pain present in both rheumatoid and osteoarthritis. One of the main
differences is that osteoarthritis is the wear and tear form of arthritis and tends to affect
the knees and hips; these are large joints bearing a lot of weight. On the other hand
rheumatoid arthritis tends to affect smaller joints like wrists, feet and hands.
Another difference is the duration of pain symptoms. In osteoarthritis pain more
brief lasting a few minutes and sometimes goes away with rest. In rheumatoid arthritis,
pain and stiffness is more intense and aggravates with rest like in the morning and may
last for more than half an hour. Age is a factor concerning both forms of arthritis when
identifying the duration of pain and its relative intensity.
2.13.2 PREVALENCE OF RHEUMATOID ARTHRITIS (RA)
Arthritis is the most common cause of disability in the US (CDC, MMWR 2007).
According to the CMS, 29 percent of all seniors (65+) have AORC (CMS, Chronic
Conditions Dashboard 2011) and specific diagnosis of RA impacts more than 1.3 million
adults (Druss et al. 2000). Of those within the Chronic Conditions Dashboard (2011), 35
percent are female and 22 percent are male. Furthermore, 23 percent are <65, 25 percent
are between 65-74, 34 percent are between 75-84, and 39 percent are 85+. Of those 6574, 25 percent have RA, 10 percent only have RA, 35 percent have 1-2 conditions, 33
percent have 3-4 conditions, and 22 percent have 5+ conditions (CMS, Chronic
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Conditions Dashboard 2011). Of those 75-84, 34 percent have RA, 6 percent only have
RA, 27 percent have 1-2 conditions, 35 percent have 3-4 conditions, and 32 percent have
5+ conditions (CMS, Chronic Conditions Dashboard 2011). Lastly, those 85+, 39
percent have RA, 3 percent only have RA, 22 percent have 1-2 conditions, 33 percent
have 3-4 conditions, and 42 percent have 5+ conditions (CMS, Chronic Conditions
Dashboard 2011). 30 percent of women 65-74 suffered from RA, 39 percent of women
75-84 also had RA, and 43 percent of women 85+ were diagnosed with RA (CMS,
Chronic Conditions Dashboard 2011). 20 percent of men ages 65-74 had RA, 27 percent
of men 75-84 suffered from RA, and 31 percent of men ages 85+ had RA (CMS, Chronic
Conditions Dashboard 2011).
2.13.3 COSTS OF ARTHRITIS
In 2006, the United States (U.S.) government spent approximately $128 billion
($80.8 billion in direct costs/$47.3 billion in indirect costs) in expenditures related to
AORC (Yelin et al. 2007). For OA and other non-traumatic joint disorders, the US spent
$62 billion of which $27.4 billion were spent on services rendered to those 65+ in years
(AHRQ, Medical Expenditure Survey 2010). Additionally, $40.3 billion were for outpatient services, 31.4 billion were spent on in-patient services and $17.4 billion on
prescriptive medications (AHRQ, Medical Expenditure Survey 2010).
2.13.4 PREVALENCE OF CO-OCCURING ARTHRITIS AND MDD
Arthritis is strongly associated with major depression (attributable risk of 18.1%),
probably through its role in creating functional limitation (Dunlop et al. 2004).
Depression and RA prevalence research results range from 13 percent to 20 percent
(Morris et al. 2011). Within a similar study (n=1,793), of those having RA, 18 percent
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had depression; additionally, 83 percent of those with depression also had anxiety
(Murphy et al. 2012). Anxiety was more common in those with RA, as it presented in 31
percent of those with RA (Murphy et al. 2012). Only half of the respondents with RA
and depression or anxiety sought help for their condition over the past year (Murphy et al.
2012).
Among adults with arthritis, depression or anxiety, 14.7 percent (5.5 million)
reported both. Most respondents with depression also had anxiety (84 percent), whereas
half of those with anxiety also had depression (49.5 percent) [Murphy et al. 2012]. 48
percent of those persons with RA reporting having “a lot” of difficulties dressing or
bathing themselves were most likely to be suffering from depression (Murphy et al.
2012). Those persons with “low” confidence in managing their arthritis or joint
symptions were 3.9 times more likely to suffer from depression than those who had
“high” confidence in managing their arthritis or joint symptoms (Murphy et al. 2012).
Those persons with RA with either “no confidence” or “low confidence” to engage in
moderate physical activity at least 3 times per week were 4.1 and 3.1 times more likely to
suffer from depression than those who had “high” confidence in engaging in physical
activity at least 3 times per week (Murphy et al. 2012). Only 60 percent of men and 53
percent of women with diagnosed depression, anxiety or both reported pursuing treatment
for such over the past twelve months; 53 percent of men are seeking treatment for RA
and 43 percent for women with an arthritic diagnosis (Murphy et al. 2012).
Patients with RA and depression have worse health outcomes, including poor
medical adherence, increased health services utilization, pain, disability and death
(Margaretten et al. 2011). In patients with RA, poor clinical characteristics and function
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are associated with subsequent depressive symptoms (Margaretten et al. 2011). RA
disease factors associated within depression in RA patients include pain, functional status
and clinical remission (Margaretten et al. 2011).
One in 10 adults, > 20 years of age, who positively screened for arthritis had
experienced a major depressive episode in the previous twelve months (Fuller-Thomson
et al. 2009). Those persons with > than two conditions to include arthritis were 2.2 times
more likely to suffer from a major depressive disorder than those only experiencing
arthritis (Fuller-Thomson et al. 2009). Likewise, those persons with > than two
conditions to include arthritis were 2.1 times more likely to suffer from suicidal ideation
than those only experiencing arthritis (Fuller-Thomson et al. 2009).
2.14 RESEARCH QUESTIONS/HYPOTHESIS
This study will examine one research question and three hypotheses:
(Q1) What is the relationship between “perceived” (P) depression and those who meet the
DSM-IV positively screened criteria for MDD?
(H1) Those persons age 65 and older who report being diagnosed by a physician as
having arthritis (P/E) will be significantly more likely to be suffering from MDD than
those who have not been diagnosed with an arthritic condition.
(H2) Those persons age 65 and older who self-report arthritis (no reported physician
diagnosis) [P/E] will be significantly more likely to be suffering from MDD than those
who have not been diagnosed with an arthritic condition.
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CHAPTER THREE: METHODS
3.1 DATA SOURCE AND STUDY POPULATION
Data from the National Epidemiological Survey on Alcohol and related
Conditions (NESARC) 2001-2002 were used to conduct the analysis. NESARC is a
nationwide household survey designed and conducted by the National Institute on
Alcohol Abuse and Alcoholism (NIAAA). NESARC used a representative sample of the
civilian, noninstitutionalized adult population in the United States, including all 50 States
and the District of Columbia. The fieldwork for the survey was completed under
NIAAA’s direction by trained U.S. Census Bureau Field Representatives who
interviewed 43,093 respondents, 18 years of age and older in face-to-face household
settings. The population of interest in this study consisted of persons age 65 years and
greater (n=8,205). The household response rate for the NESARC was 89 percent, and
the person response rate was 93 percent, yielding an overall response rate of 81 percent.
("National Epidemologic Survey on Alcohol and Related Conditions," 2001-2002)
3.2 STUDY VARIABLES
Dependent Variable:
Major depression was defined by utilizing diagnostic criteria identified in the
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) and the specific
questions outlined within the NESARC survey. The diagnostic screening for major
depression consists of nine criteria in which one of the symptoms present must be either
depressed mood or loss of interest or pleasure
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Per the DSM-IV, a respondent must have either (1) depressed mood or (2) a loss
of interest or pleasure in order to be diagnosed with major depression (Table 3.1). If this
requirement is met, the respondent then must respond positively to at least four of seven
criteria in order to screen positively for major depression. The question which addressed
the depressed mood criteria was: “In your entire life, have you ever had a time when you
felt sad, blue, depressed, or down most of the time for at least two weeks?” The second
question asked “In your entire life, have you ever had a time, lasting at least two weeks,
when you didn’t care about the things that you usually cared about or when you didn’t
enjoy the things you usually enjoy?” A positive response to this question was coded as
affirming a loss of interest or pleasure.
The next four questions addressed the DSM-IV diagnostic requisite for a
diagnosis of depression of “significant weight loss when not dieting or weight gain (e.g.,
a change of more than 5% of body weight in a month), or decrease or increase in appetite
nearly every day”. This criteria was evaluated by a series of four questions: “Lose at
least 2 pounds a week for several weeks or at least 10 pounds altogether within a month
other than when you were physically ill or dieting?”, “Lose your appetite nearly every
day for at least two weeks?”, “Gain at least 2 pounds a week for several weeks or at least
10 pounds altogether within a month (other than when you were growing or pregnant)?”,
and “Find that you wanted to eat a lot more than usual for no special reason, most days
for at least two weeks?” If the respondent identified that any of the four questions were
applicable, they were positively coded for standard three (Table 3.1).
The fourth DSM-IV criteria, “insomnia or hypersomnia nearly every day,” was
captured within the NESARC survey by three questions: “Have trouble falling asleep
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nearly every day for at least two weeks?”, “Wake up too early nearly every day for at
least two weeks?”, and “Sleep more than usual nearly every day for at least two weeks?”
If the individual responded that any of the three questions applied, they were positively
coded for standard four (Table 3.1).
The fifth DSM-IV criterion required a positive response with regard to three
questions. The questions were “Move or talk much more slowly than usual, most days
for at least two weeks?”, “Become so restless that you fidgeted or paced most of the time
for at least two weeks?”, and “Become so restless that you felt uncomfortable for at least
two weeks?” The related DSM-IV criterion state that “psychomotor agitation or
retardation nearly every day (observable by others, not merely subjective feelings of
restlessness or being slowed down)” must be met in order to meet the requisite needed for
diagnosis (Table 3.1).
The sixth DSM-IV criteria asks the respondent if he/she, “Feels tired nearly all of
the time or get tired easily most days for at least two weeks, even though you weren’t
doing more than usual?” The DSM-IV suggests that “fatigue or loss of energy nearly
every day” must be met in order to meet the requirements under criterion six (Table 3.1).
The seventh DSM-IV criterion evaluated the following two questions: “Feel
worthless nearly all of the time for at least two weeks?”, and “Feel guilty about things you
normally wouldn’t feel guilty about, most of the time for at least two weeks?” Again, if
the respondent answered positively for either of the questions, it was coded as meeting
the requirement for criterion seven. The DSM-IV measurement for criteria seven stated
“feelings of worthlessness or excessive or inappropriate guilt (which may be delusional)
nearly every day (not merely self-reproach or guilt about being sick) [Table 3.1].
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The eighth DSM-IV criterion asked the following two questions: “Having trouble
concentrating or keeping your mind on things, most days for at least two weeks?”, and
“Find it harder than usual to make decisions, most of the time for at least two weeks?” A
positive response for either question was coded as a positive association with requirement
eight. The DSM-IV identifies the eighth measurement as “diminished ability to think or
concentrate, or indecisiveness, nearly every day (either by subjective account or as
observed by others) [Table 3.1].
The final requisite DSM-IV criterion (ninth) inquired regarding the following four
questions: “Attempt suicide?”, “Think about committing suicide?”, “Feel like you wanted
to die?”, and “Think a lot about your own death?” Any positive response to any of the
four questions was coded as meeting the requirements for the ninth criteria. The DSMIV identifies the ninth standard as “recurrent thoughts of death (not just fear of dying),
recurrent suicidal ideation without a specific plan, or a suicide attempt or a specific plan
for committing suicide” (Table 3.1).
Coding was conducted while following the DSM-IV requirements for major
depression diagnosis. The DSM-IV states that “five (or more) of the listed symptoms
have been present during the same two week period and represent a change from previous
functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of
interest or pleasure” (Table 3.1). SAS coding was conducted to ensure that either criteria
one or two was met while including that at least four of the remaining standards were also
deemed positive by the respondent. This allowed for the positive screening of major
depression within the older population surveyed by the NESARC study.

69

Table 3.1 Coding of Major Depression Criteria Among Population 65 Years and Older,
NESARC 2001-2002.

Diagnostic
indicator

Depressed mood

Criteria
or
Subset

1

Question (s)

Coding

“In your entire life, have you ever
had a time when you felt sad, blue,
depressed, or down most of the time
for at least two weeks?”

Yes
See Criteria 2
No
See Criteria 2
Yes
Meet at least 4 of 7
criteria below
No (Yes, Criteria 1)
Meet at least 4 of 7
criteria below
No (No, Criteria 1)
No major depression
At least 4 of 7 positive
Yes
Positive Criteria 3
No

“In your entire life, have you ever
had a time, lasting at least two
weeks, when you didn’t care about
the things that you usually cared
about or when you didn’t enjoy the
things you usually enjoy?”
Loss of interest or
pleasure
Weight

2
3

Lose Weight

3/1

Lose Appetite

3/2

Consistent Weight
Gain

3/3

Excessive Eating
Sleeping Patterns

3/4
4

“Lose at least 2 pounds a week for
several weeks or at least 10 pounds
altogether within a month other than
when you were physically ill or
dieting?”
“Lose your appetite nearly every day
for at least two weeks?”
“Gain at least 2 pounds a week for
several weeks or at least 10 pounds
altogether within a month (other than
when you were growing or
pregnant)?”
“Find that you wanted to eat a lot
more than usual for no special
reason, most days for at least two
weeks?”

“Have trouble falling asleep nearly
every day for at least two weeks?”
Trouble Sleeping

4/1
“Wake up too early nearly every day
for at least two weeks?”

Waking Early

4/2
“Sleep more than usual nearly every
day for at least two weeks?”

Excessive Sleep

Check Subset 3/2-3/4
Yes
Yes
Positive Criteria 3
No
Check Subset 3/4
Yes
Positive Criteria 3
No
Negative Criteria 3 if No
to all Subsets (3/1-3/4)
Yes
Positive Criteria 4
No
Check Subset 4/2
Yes
Positive Criteria 4
No
Check Subset 4/3
Yes
Positive Criteria 4
No
Negative Criteria 4 if No
to all Subsets (4/1-4/3)

4/3
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Anxious Symptoms

5
“Move or talk much more slowly
than usual, most days for at least two
weeks?”

Slowed Speech

5/1
“Become so restless that you fidgeted
or paced most of the time for at least
two weeks?”

Restlessness 1

5/2
“Become so restless that you felt
uncomfortable for at least two
weeks?”

Restlessness 2
Fatigue

Fatigue/Lose of
Energy
Worthlessness/Guilt

Worthlessness

5/3
6

“Feel worthless nearly all of the time
for at least two weeks?”

Yes
Positive Criteria 7
No
Check Subset 7/2
Yes
Positive Criteria 7
No
Negative Criteria 7 if No
to all Subsets (7/1-7/2)

6/1
7

7/1

7/2
8

8/1
“Find it harder than usual to make
decisions, most of the time for at
least two weeks?”

Decision-making
Suicide

8/2
9
“Attempt suicide?”

Attempted

9/1
“Think about committing suicide?”

Considering

9/2
“Feel like you wanted to die?”

Feeling of positive
death

Check Subset 5/2
Yes
Positive Criteria 5
No
Check Subset 5/3
Yes
Positive Criteria 5
No
Negative Criteria 5 if No
to all Subsets (5/1-5/3)
Yes
Positive Criteria 6
No
Negative Criteria 6 if No
to Subset 6/1

“Having trouble concentrating or
keeping your mind on things, most
days for at least two weeks?”
Concentration

No

“Feel tired nearly all of the time or
get tired easily most days for at least
two weeks, even though you weren’t
doing more than usual?”

“Feel guilty about things you
normally wouldn’t feel guilty about,
most of the time for at least two
weeks?”
Guilt
Cognitive Ability

Yes
Positive Criteria 5

9/3
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Yes
Positive Criteria 8
No
Check Subset 8/2
Yes
Positive Criteria 8
No
Negative Criteria 8 if No
to all Subsets (8/1-8/2)
Yes
Positive Criteria 9
No
Check Subset 9/2
Yes
Positive Criteria 9
No
Check Subset 9/3
Yes
Positive Criteria 9
No

“Think a lot about your own death?”

Think of own death

9/4

Check Subset 9/4
Yes
Positive Criteria 9
No
Negative Criteria 9 if No
to all Subsets (9/1-9/4)

Independent Variable of Interest:
Within this study, there will be two independent variables of interest. The first
variable will be the patient’s identifying that they have arthritis without a physician’s
diagnosis. The second variable will be the patient’s account that a physician has told
them they have arthritis. This will be utilized to examine Andersen’s theoretical
framework in which the outcome category identifies the important of both the “perceived
health status” and the “evaluated health status” within the context of the developed
blended framework.
Control Variables:
Both Andersen’s (1995) and House’s (2001) theoretical framework with be
utilized to describe the “control variables” description. Andersen’s model provides a
particular focus on access to health services and includes the following categorical areas:
environment, population characteristics, health behavior, and outcomes. Each of these
categories has particular subcategories that will be evaluated for proper variable
selection. Likewise, House’s (2001) model will be utilized to account for variables based
on categorical elements within the model, focusing more on the psychological and
behavioral element of wellness and prevention (Figure 2.6). These categories are as
follows: race/ethnicity, gender, social/political/economic conditions and policy,
socioeconomic status, explanatory variables (including medical care/insurance,
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psychosocial risk factors, and physical/chemical and social environmental hazards), and
health outcomes. The aim is to ensure the inclusion of cognitive/behavioral and
psychological variables into each model (as appropriate) to account for collaborative,
coordinated, and integrated care to reduce the potential of comorbid and/or future chronic
care. Limitations are related to the NESARC dataset and the particular variables
available for selection and modeling.
Table 3.2 represents a combination of the blended framework (Figure 2.6) and
control variable selection. The description below will focus on the methods for NESARC
data coding as well as the categorization of the blended framework (categories: (1)
environment (2) individual & situational characteristics (3) short-term health behavior (4)
enduring health outcome. It is also important to note that although we have categorized
variables the subcategories developed (Table 3.2) blend into like categories,
demonstrating the potential influence of addressed and non-addressed issues concerning
health and impacting the enduring health outcome over time. Lastly, mutability is
incorporated in the variable classification model (Andersen 1995) showing which
variables have the potential for intervention within the selection criteria.
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Table 3.2 Andersen (1995) / House’s (1981, 2001) Blended Conceptual Framework Control Variable Categorization
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Within the category of “environment”, there are two developed subcategories:
“health care system” and external environment”. The following two control variables
were selected under “health care system”, given their direct impact on access: (1)
medicare (2) private insurance. The NESARC dataset surveyed the “medicare” variable
by asking, “currently covered by medicare” with a dichotomous answer of “yes/no”.
“Dichotomous” in description going forward will mean a “yes/no” response within the
dataset unless otherwise described. Likewise, the “private insurance” variable was
dichotomous and asked, “currently covered by private health insurance”.
The dichotomous variable “father/mother (alcohol)” will be a recoded variable
from two dichotomous questions within the dataset, “blood/natural father ever an
alcoholic or problem drinker” and “blood/natural mother ever an alcoholic or problem
drinker”. The newly created variable (parental alcohol) will be coded as (1) none (2)
either (3) both. Likewise, “father/mother (depressed) will be recoded from two
dichotomous questions, “blood/natural father ever depressed” and “blood/natural mother
ever depressed”. This newly recoded variable (parental depressed) will be constructed as
(1) none (2) either (3) both.
The next category for which control variables need to be described is “individual
and situational characteristics.” This section will only describe those variables within the
“predisposing characteristics” subcategory, although other subcategories blend into this
category. The “place of birth” variable identified whether the respondent was born
within the US or outside the boundaries of the fifty states. “Race/Ethnicity” was coded
into the following categories: Non-Hispanic White, Non-Hispanic Black, Hispanic, NonHispanic Other. All categories inconsistent with selections within the NESARC survey
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were distributed into the Non-Hispanic Other category. “Gender” identified whether the
respondent was male or female. “Health status” accounted for the perception of the
respondent’s current health within the following five levels: excellent, very good, good,
fair, and poor. The “region” variable divided the geographical area of the US into four
areas of interest: Northeast, Midwest, South, and West. “Age” was stratified into the
following three levels: 65-74 years (youngest old), 75-84 years (middle old), and 85+
years (oldest old).
The third category of evaluation within the blended framework is the “short-term
health behavior” category. The following subcategories and elements of subcategories
(perceived health) will be accounted for in this category both within variable description
and incremental modeling: (1) stressors: objective biopsychosocial conditions conducive
to diminishing health (2) psychosocial risk factors (3) perceived/evaluated need (4)
perceived health (physical). Within subcategory (1), “troubled” is dichotomous and
coded as “felt troubled because of way you felt/often wished could get better”. “Argue”
is also dichotomous and coded as “had arguments/friction with family, friends, people at
work, or anyone else”. “Not do” is dichotomous and accounts as “couldn’t do things
usually did/wanted to do”. “Did less”, again is dichotomous, and asks respondent if “did
a lot less than usual or were less active”. “Avoid” is dichotomous and is coded as “avoid
jobs or tasks that deal with a lot of people”. “Not open” is a dichotomous variable asking
if the respondent “find it hard to be open even with people you are close to”. “Not help”
is dichotomous and asks respondent if “hard to let others help if they don’t agree to do
things exactly the way you want”. “Stubborn” is dichotomous and asks “have others told
you that you are stubborn or rigid”. “Not close” is another dichotomous variable asking
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the respondent “are there very few people you’re really close to outside your immediate
family”. Lastly, “does not care” is dichotomous and asks “the sort of person who doesn’t
care about what people think of you”.
The next subcategory for which variables will be examined is under the
“psychosocial risk factors” categorization and will be associated with the category of
“individual and situational characteristics”. “Depend is coded as dichotomous and asks if
the respondent “depends on others to handle important areas in life”. “Drink” refers to
the consumption of alcohol and was divided into three levels of interest: current drinker,
ex-drinker, and lifetime abstainer. “Alone” was recoded to produce a dichotomous
variable capturing “living alone” or “not living alone”. “Worry” is a dichotomous
variable and asked if they “worry a lot about being left alone to take care of self”.
Another subcategory of short-term health behavior, “perceived / evaluated need”
will utilize several NESARC dataset control variables. “Financial hardship” was a
dichotomous variable that asked if the respondent “experienced major financial crisis,
bankruptcy, or unable to pay bills on time in last 12 months”. “DSI/I” (death serious
illness/injury) Death, Serious Illness/Injury (DSI/I) is a hybrid variable, which takes into
account if the respondent experienced death or serious illness/injury of a close family
member or friend within the previous 12 months. DSI/I is a combination of variables to
include “death” and “injury” questions within the dataset. The particular question
regarding death extracted from the survey was “any family members or close friends die
in the past twelve months?” Likewise, the specific question associated with illness/injury
was “any family members or close friends had serious illnesses or injuries in the past
twelve months? Coding was conducted to capture the significance of either of these
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instances of occurring. DSI/I is divided into three levels of measurement: none, either, or
both.
“Education” was recoded into the following four levels of educational
achievement: some high school or less, completion of high school, some college, and
college graduate. The original question stratified the sample into fourteen different
academic standards. However, the cross sectional nature of this study required the
recoding of levels in order to maintain sample sizes significant enough to provide
accuracy.
The “Income level” variable was based on total personal income and not family
income. The NESARC survey stratified total personal income into seventeen identifiable
categories. The cross sectional representation of this study required the limiting of
categorical levels, thus personal income was adjusted into five levels to include the
following: $0-10,000, $10,001-$20,000, $20,001-$30,000, $30,001-$40,000, and
$40,001. “SSI Income” was a dichotomous variable asking the respondent if he or she
“personally received supplemental security income (SSI) in last 12 months”.
“Medicaid” is a dichotomous variable and it was determined to be recorded here
as a “need-based” variable versus under the category of “health care system”, following a
blended model favoring House versus Andersen’s health services (access) approach. The
variable is dichotomous and stated “currently covered by Medicaid” within the survey.
“Food stamps” was another dichotomous variable included within the “need”
subcategory.
“Accomplished less (physical)” asked the respondent “during the past 4 weeks,
how often accomplished less than would like as a result of physical health”. The options
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for response are as follows: (1) all of the time (2) most of the time (3) some of the time
(4) a little of the time (5) none of the time. Likewise, the variable “accomplished less
(emotional)” asks the respondent “during the past 4 weeks, how often accomplished less
than would have liked as result of emotional problems”. The options for response are as
follows: (1) all of the time (2) most of the time (3) some of the time (4) a little of the time
(5) none of the time. Another variable, “physical/psychological health” asked “during the
past 4 weeks, how often physical health or emotional problems interfered with social
activities”. The options for response are as follows: (1) all of the time (2) most of the
time (3) some of the time (4) a little of the time (5) none of the time. “Pain” was another
variable of interest asking the respondent “during past 4 weeks, extent to which pain
interfered with normal work. The response options were as follows: (1) not at all (2) a
little bit (3) moderately (4) quite a bit (5) extremely.
The following variables described are those physiological variables in which the
respondent “perceives” to have the particular listed ailment. “Arthritis” is a dichotomous
variable in which the respondent was asked “had arthritis in last 12 months”. It is
important to note here as well that “arthritis” is highlighted (Table 3.2), as it is the
independent variable of interest within the study.
“High blood pressure/hypertension” is dichotomous as well and asked if the
respondent “had high blood pressure or hypertension in last 12 months”. “Chest pain”
was another dichotomous variable and the survey inquired if the respondent “had chest
pain or angina pectoris in last 12 months”. “Rapid heart” was also a dichotomous
variable asking if “had rapid heartbeat or tachycardia in last 12 months”. “Heart attack”
is dichotomous as well asking if the respondent “had heart attack or myocardial infarction
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in last 12 months”. Lastly, “other heart disease” was dichotomous and asked if “had any
other form of heart disease in last 12 months”.
The final category reviewed by the blended framework is “enduring health
outcome”. Physical health need (evaluated) is included here and will include all the
physical areas of diagnoses (reported diagnosed by a doctor) in the previous paragraph
minus the inclusion of “alcohol abuse/dependence” and “nicotine dependence”. The
NESARC dataset established both “alcohol abuse/dependence” and “nicotine
dependence” through the “evaluated” review of coding for diagnoses, much the same as
seen later, concerning the “evaluated” health (mental) within the dissertation. “Alcohol
abuse/dependence” was reported as “alcohol abuse/dependence in last 12 months” with
responses in coding as such: (0) no alcohol diagnosis (1) alcohol abuse only (2) alcohol
dependence only (3) alcohol abuse and dependence. “Nicotine dependence” is a
dichotomous variable reported as “nicotine dependence – lifetime”. .
“Arthritis (E)” [Table 3.2] is a dichotomous variable in which the respondent was
asked “did doctor or other health professional confirm diagnosis”.
“High blood pressure/hypertension (E)” is dichotomous as well and asked if the
respondent “did doctor or other health professional confirm diagnosis”. “Chest pain (E)”
was another dichotomous variable and the survey inquired if the respondent “did doctor
or other health professional confirm diagnosis”. “Rapid heart (E)” was also a dichotomous
variable asking if “did doctor or other health professional confirm diagnosis”. “Heart
attack (E)” is dichotomous as well asking if the respondent “did doctor or other health
professional confirm diagnosis”. Lastly, “other heart disease (E)” was dichotomous and
asked if “did doctor or other health professional confirm diagnosis”.
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3.3 ANALYTICAL APPROACH
Analytic procedures were conducting by utilizing SAS statistical analysis
software (Cary, North Carolina) to emulate the requirement within the DSM-IV.
Frequency distributions were compared prior to and after recoding variables to ensure
that proper alterations were similar to those originally intended within the NESARC
survey. SUDAAN was used to account for the complex weighted sampling structure of
the NESARC.
The bivariate analysis of each variable, as it related to major depression, was
conducted while using both SAS and SUDAAN and the cross-tabulation procedure. Chisquared tests were also conducted to establish the relationship between characteristics
and DSM-IV criteria-based MDD. Logistics regression was utilized to produce bivariate
odds ratios for major depression.
Multiple logistic regression analysis was conducted using an incremental
approach to modeling while accounting for variable categorizations within both Andersen
(1995) and House’s (2001) conceptual frameworks. The incremental modeling will
consist of “blending” the conceptualized framework subcategories with the “perceived”
and “evaluated” variable responses as outlined in Figure 2.6 and Table 3.2. Individual
models will be analyzed while providing stabilizing results associated with each of the
subcategories of interest. Variable modeling demonstrated the relationship between
arthritis and having or not having MDD.
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The formula utilized given the previously listed variables is as follows:
)
)
)
) )
Y = β 0 + β1 X 1 + β 2 X 2 + .......... .. + β n X n + ε

Where:

)
Y = log of the predicted odds of having major depression;
)
β 0 = intercept;
)

β 1 = regression coefficient for the independent variable X1;
)
β 2 = regression coefficient for the independent variable X2;
)
β n = regression coefficient for the nth independent variable;
X1, X2, X3, X4,…….., Xn are independent covariates included in
the model; and ε = error term
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CHAPTER FOUR: RESULTS
4.1 DESCRIPTION OF THE POPULATION
Descriptive Characteristics (Predisposing Characteristics):

There were 8,205 seniors surveyed within the NESARC dataset (2001-02). Of
these, 609 reported having arthritis (P/E) [Table 4.1]. Those born in the U.S. accounted
for 88.5% of those surveyed within the study and 70.5% of those surveyed were
considered “Non-Hispanic White” [Table 4.1]. When considering gender, 62.2% were
female and 37.8% were male. Those responding to have either “fair” or “poor” health
were 34.8% while those identifying to have “excellent” or “very good” health were
33.3% (Table 4.1). Those older persons surveyed to be 65-74 in years of age were
52.4%, those 75-84 were 36.2%, and those 85+ in age were 11.4%. Those with “some
college” or “college graduates” were 47.2% compared to those with “some high
school/less” and “complete high school” to be 64.7% (Table 4.1). Seniors reporting to
have Medicare was 93.0%, Medicaid was 10.5% and private insurance was 56.6%.
Income levels about $30,001 was reported by 32.6% of seniors while 49.0% elderly
persons surveyed reported having incomes below $20,000 per year. Of the older
population surveyed, 7.4% reported receiving SSI income and 4.7% disclosed receiving
food stamps. Financial hardship (previous 12 months) was reported by 3.6% of seniors in
the survey (Table 4.1).
Descriptive Characteristics (Biopsychosocial Conditions):

Seniors within the survey disclosed that 8.0% had biological mothers who were
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depressed and 4.2% had depressed fathers (Table 4.2). The elderly sample also reported
that 1.8% had fathers who were alcoholics and 10.8% had alcoholic mothers (Table 4.2).
Those who either had lost a family member or close friend (previous 12 months) or had a
close friend suffering from a serious illness or injury (DSI/I) were 30.4% and those
whom had experienced “both” were 22.7% in number. The sample also reported that
8.0% considered themselves to be “not open”, 15.0% would not ask for help when
needed, and 29.3% considered themselves to be “stubborn” (Table 4.2).
Descriptive Characteristics (Medical Comorbidities):

Seniors experiencing self-reported pain “moderately”, “quite a bit” and “extremely”
were 35.4% (Table 4.3). Elderly persons within the sample reporting to have
hypertension (P/E) were 48.7%, those reporting chest pain (P/E) were 12.7%, and elderly
persons reporting previously experiencing a heart attack were 3.3% (Table 4.3). Older
persons within the survey who reported having a rapid heartbeat (P/E) were 11.5% while
those reporting any “other heart disease (P/E)” were 8.8% (Table 4.3). Those persons
within the survey evaluated (E) for “alcohol abuse only” were 11.6% while those who
were evaluated (E) for both alcohol abuse and dependence were 2.8% (Table 4.3).
Seniors within the survey whom were evaluated (E) nicotine dependence were 8.3%
(Table 4.3).
4.2 DESCRIPTIVE / BIVARIATE ANALYSIS [MDD]
Risk Factors (Predisposing and Enabling Characteristics):

Predisposing and enabling characteristics were controlled for given their potential
impact of influencing multivariate outcomes with regards to MDD.
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Those persons experiencing arthritis (P/E) were significantly more likely to suffer
from MDD [OR 2.00; 95% CI: 1.52, 2.65] than those whom did not suffer from arthritis
(P/E). Women were significantly more likely to suffer from MDD than men [OR 2.09;
95% CI: (1.73, 2.53)]. Nearly16 percent of all women were positively screened for MDD
contrasted with only 8 percent of senior males.
Those seniors in either “fair” [OR 1.67; 95% CI: (1.26, 2.20)] or “poor” [OR 2.48;
95% CI: (1.82, 3.37)] were significantly more likely to suffer from MDD than those selfreporting “excellent” health condition. Those in “fair” health status and screening
positive for MDD were nearly 15 percent of the “fair” sample while those in “poor”
health status screening positive for MDD were nearly 21 percent of those sampled within
the “poor” health status sub-category. Comparatively, only 9 percent of those in
“excellent” health status suffered from MDD (Table 4.1).
Seniors ages 75-84 were significantly less likely [OR 0.80; 95% CI: (0.67, 0.95)] to
suffer from MDD than those ages 65-74 (referent group); and those 85+ were also
significantly less likely to suffer from MDD [OR 0.54; 95% CI: (0.41, 0.71)] than those
seniors in the referent group (Table 4.1).
Seniors who reportedly accepted SSI income were significantly more likely to be
suffering from MDD [OR 1.49; 95% CI: (1.12, 1.98)] than those who did not accept or
qualify for SSI income. Likewise, those who reportedly accepted food stamps were
significantly more likely to suffer from MDD [OR 1.88; 95% CI: (1.30, 2.73)] than those
who did not accept or qualify for food stamps (Table 4.1).
Seniors who self-reported financial hardship over the past 12 months were
significantly more likely to experience MDD [OR 4.00; 95% CI: (2.94, 5.45)]. Those
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seniors who also report both receiving SSI income [OR 1.49; 95% CI: (1.12, 1.98)] and
food stamps [OR 1.88; 95% CI: (1.30, 2.73)] were significantly more like to suffer from
MDD.
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Table 4.1 Descriptive Characteristics and Risk Factors for Major Depression, persons 65 and older, 2001-2002 NESARC
Total
n=8,205
Frequency / %
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Hypothesized IV
Arthritis (P/E)**
Yes
No
Predisposing
characteristics
Origin of birth
U.S. born
Non-U.S. born
Race/Ethnicity
Non-Hispanic White
Non-Hispanic Black**
Hispanic
Non-Hispanic other
Sex**
Male
Female
Health status**
Excellent
Very good
Good
Fair**
Poor**

No Major Depression
n=7,148
%(se)

Major Depression
n=1,057
%(se)

OR forMajor
Depression
OR (LCL, UCL)

p-value
0.00

609 (7.4)
7,596 (92.6)

78.82 (2.24)
88.17 (0.44)

21.18 (2.24)
11.83 (0.44)

2.00 (1.52, 2.65)
1.00

7,243 (88.5)
942 (11.5)

87.67 (0.47)
86.41 (1.57)

12.33 (0.47)
13.59 (1.57)

0.89 (0.67, 1.19)
1.00

0.44

5,776 (70.5)
1,355 (16.5)
895 (10.9)
171 (2.1)

87.44 (0.51)
90.06 (1.07)
87.49 (1.49)
84.64 (2.64)

12.56 (0.51)
9.94 (1.07)
12.51 (1.49)
15.36 (2.64)

1.00
0.77 (0.60, 0.99)
1.00 (0.74, 1.34)
1.26 (0.84, 1.89)

3,104 (37.8)
5,101 (62.2)

91.91 (0.59)
84.43 (0.65)

8.09 (0.59)
15.57 (0.65)

1.00
2.09 (1.73, 2.53)

983 (12.0)
1,749 (21.4)
2,580 (31.6)
1,938 (23.7)
915 (11.2)

90.45 (1.02)
90.66 (0.78)
88.45 (0.76)
85.05 (1.00)
79.28 (1.60)

9.55 (1.02)
9.34 (0.78)
11.55 (0.76)
14.95 (1.00)
20.72 (1.60)

1.00
0.98 (0.73, 1.31)
1.24 (0.93, 1.65)
1.67 (1.26, 2.20)
2.48 (1.82, 3.37)

0.12
0.04
0.98
0.25
0.00

0.00
0.87
0.14
0.00
0.00

Total
n=8,205
Frequency / %
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Age**
65-74
75-84**
85+**
Region
Northeast
Midwest
South
West**
Education
Some high school/less
Complete high school
Some college
College graduate
Medicare
Yes
No
Medicaid
Yes
No
Private Insurance
Yes
No

No Major Depression
n=7,148
%(se)

Major Depression
n=1,057
%(se)

OR for Major
Depression
OR (LCL, UCL)

4,301 (52.5)
2,973 (36.2)
931 (11.3)

86.10 (0.60)
88.56 (0.72)
92.02 (0.97)

13.90 (0.60)
11.44 (0.72)
7.98 (0.97)

1.00
0.80 (0.67, 0.95)
0.54 (0.41, 0.71)

1,684 (20.5)
1,758 (21.4)
3,135 (38.3)
1,628 (19.8)

89.23 (0.95)
87.30 (0.86)
87.53 (0.75)
86.26 (0.95)

10.77 (0.95)
12.70 (0.86)
12.47 (0.75)
13.74 (0.95)

1.00
1.21 (0.94, 1.55)
1.18 (0.93, 1.50)
1.32 (1.02, 1.70)

2,645 (32.2)
2,665 (32.5)
1,206 (14.7)
1,689 (20.6)

87.36 (0.82)
87.66 (0.72)
87.59 (1.12)
87.69 (0.92)

12.64 (0.82)
12.34 (0.72)
12.41 (1.12)
12.31 (0.92)

1.03 (0.81, 1.30)
1.00 (0.82, 1.23)
1.01 (0.77, 1.32)
1.00

7,629 (93.0)
576 (7.0)

87.40 (0.47)
90.03 (1.73)

12.60 (0.47)
9.97 (1.73)

p-value
0.03
0.01
0.00
0.24
0.14
0.17
0.03
0.99
0.80
0.98
0.95
0.19

1.30 (0.88, 1.94)
1.00
0.45

865 (10.5)
7,340 (89.5)

86.54 (1.34)
87.67 (0.50)

13.46 (1.34)
12.33 (0.50)

1.11 (0.85, 1.44)
1.00

4,647 (56.6)
3,558 (43.4)

87.44 (0.59)
87.78 (0.68)

12.56 (0.59)
12.22 (0.68)

1.03 (0.87, 1.22)
1.00
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Total
n=8,205
Frequency / %
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Income level
$0-$10,000
$10,001-$20,000
$20,001-$30,000
$30,001-$40,000
$40,001-higher
SSI Income**
Yes
No
Food Stamps**
Yes
No
Financial hardship**
Yes
No

1,709 (20.8)
2,312 (28.2)
1,506 (18.4)
949 (11.6)
1,729 (21.0)
607 (7.4)
7,598 (92.6)

No Major Depression
n=7,148
%(se)
86.40 (0.91)
86.55 (0.88)
88.27 (0.96)
89.21 (1.12)
87.79 (0.90)
82.86 (1.88)
87.82 (0.47)

Major Depression
n=1,057
%(se)
13.60 (0.91)
13.45 (0.88)
11.73 (0.96)
10.79 (1.12)
12.21 (0.90)
17.14 (1.88)
12.18 (0.47)

OR for Major
Depression
OR (LCL, UCL)
1.13 (0.90, 1.42)
1.12 (0.90, 1.39)
0.96 (0.74, 1.22)
0.87 (0.66, 1.15)
1.00

p-value
0.20
0.29
0.32
0.71
0.32
0.01

1.49 (1.12, 1.98)
1.00
0.00

387 (4.7)
7,818 (95.3)

79.29 (3.03)
87.81 (0.45)

20.71 (3.03)
12.19 (0.45)

1.88 (1.30, 2.73)
1.00
0.00

293 (3.7)
7853 (96.3)

65.10 (3.32)
88.18 (0.44)

34.90 (3.32)
11.82 (0.44)

4.00 (2.94, 5.45)
1.00

Risk Factors (Biopsychosocial Conditions):

Biopsychosocial conditions were measured to account for the behavioral and
psychological responses relating to the overall health condition of those potentially
screening for MDD.
Those seniors whose biological mother [OR 4.69; 95% CI: (3.76, 5.84)] or father
[OR 3.80; 95% CI: (2.83, 5.11)] were depressed were significantly more likely to suffer
from MDD than those who reported their biological mother or father not being depressed
as compared to the results within (Table 4.2).
Those seniors who father was self-reported to have been an alcoholic [OR 3.04; 95% CI:
(1.97, 4.71)] and those who reported their mother to have been an alcoholic [OR 1.86;
95% CI: (1.50, 2.30)] were significantly more likely to screen positive for MDD.
Those seniors who either had a close family member or friend die (last 12 months)
or had a close family member or friend experience serious injury or illness (DSI/I) [Table
4.2] were significantly more likely to suffer from MDD [OR 1.56; 95% CI: (1.28, 1.90)]
than those who did not and, if they experienced “both”, they were also significantly more
likely to suffer from MDD [OR 2.00; 95% CI: (1.64, 2.43)] than those who did not report
an experience of any of the conditions above.
Those seniors surveyed who were “not open” [OR 2.48; 95% CI: (1.98, 3.11)], did
not ask for help when needed [OR 1.77; 95% CI: (1.46, 2.15)], and self-reported to be
“stubborn” [OR 1.60; 95% CI: (1.35, 1.89)] were all significantly more likely to suffer
from MDD than those who did not report the listed conditions above (Table 4.2).
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Table 4.2 Descriptive Characteristics and Risk Factors for Major Depression, persons 65 and older, 2001-2002 NESARC
Total
n=8,205
Frequency / %
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Biopsychosocial
conditions
Mother depressed**
Yes
No
Father depressed**
Yes
No
Father (Alcohol)**
Yes
No
Mother
(Alcohol)**
Yes
No
DSI/I**
None
Either**
Both**
Not Open**
Yes
No
Not Help**
Yes

No Major
Depression
n=7,148 %(se)

Major
Depression
n=1,057 %(se)

OR for Major
Depression
OR (LCL, UCL)

p-value

0.00
654 (9.2)
6,461 (90.8)

65.87(2.08)
90.05 (0.47)

34.13 (2.08)
9.95 (0.47)

4.69 (3.76, 5.84)
1.00
0.00

339 (5.0)
6,454 (95.0)

68.37 (3.11)
89.15 (0.45)

31.36 (3.11)
10.85 (0.45)

3.80 (2.83, 5.11)
1.00

147 (1.9)
7,797 (98.1)

70.16 (4.42)
87.74 (0.46)

29.84 (4.42)
12.26 (0.46)

3.04 (1.97, 4.71)
1.00

0.00

0.00
866 (11.2)
6,873 (88.8)
3,834 (47.3)
2,442 (30.2)
1,818 (22.5)
639 (8.1)
7,287 (91.9)

80.43 (1.60)
88.40 (0.46)
90.63 (0.55)
86.13 (0.78)
82.88 (1.17)
75.39 (2.05)
88.38 (0.44)

19.57 (1.60)
11.60 (0.46)
9.37 (0.55)
13.87 (0.78)
17.12 (1.17)
24.61 (2.05)
11.62 (0.44)

1.86 (1.50, 2.30)
1.00
1.00
1.56 (1.28, 1.90)
2.00 (1.64, 2.43)

0.00
0.00
0.00
0.00

2.48 (1.98, 3.11)
1.00
0.00

1,202 (15.2)

81.23 (1.24)

18.77 (1.24)

1.77 (1.46, 2.15)

No
Stubborn**
Yes
No

Total
n=8,205
Frequency / %
6,686 (84.8)

No Major
Depression
n=7,148 %(se)
88.48 (0.50)

Major
Depression
n=1,057 %(se)
11.52 (0.50)

OR for Major
Depression
OR (LCL, UCL)
1.00

p-value
0.00

2,350 (29.7)
5,558 (70.3)

83.58 (0.91)
89.05 (0.51)

16.42 (0.91)
10.95 (0.51)

1.60 (1.35, 1.89)
1.00
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Risk Factors (Medical Comorbidities):

Medical comorbidities were added to the model to control for physiological factors
associated with MDD or depression (P).
Seniors within the survey who self-reported having pain “not at all” [OR 0.40; 95%
CI: (0.30, 0.52)] or “a little bit” [OR 0.64; 95% CI: (0.48, 0.85)] were significantly less
likely to experience MDD than those who reported having “extreme” amounts of pain
(Table 4.3).
Those persons reporting “hypertension (P/E)” [OR 1.33; 95% CI: (1.13, 1.56)],
“chest pain (P/E) [OR 2.60; 95% CI: (2.10, 3.20)] and “rapid heartbeat” [OR 2.03; 95%
CI: (1.63, 2.52)] were significantly more likely to experience MDD compared to those
who did not report having each of these particular conditions (Table 4.3).
Elderly persons who reported “other heart disease” [OR 1.75; 95% CI: (1.38, 2.21)]
were significantly more likely to suffer from MDD than those who did not report having
another heart disease (Table 4.3).
Those older persons surveyed who had both an evaluated (E) alcohol abuse and
dependency condition [OR 2.40; 95% CI: (1.70, 3.39)] were significantly more likely to
suffer from MDD than those without an evaluated (E) alcoholic diagnosis (Table 4.3).
Surveyed seniors who were evaluated (E) to have “nicotine dependence” [OR 2.47;
95% CI: (1.95, 3.13)] were significantly more likely to experience MDD than those
without an evaluated condition of “nicotine dependence” (Table 4.3).
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Table 4.3 Descriptive Characteristics and Risk Factors for Major Depression, persons 65 and older, 2001-2002 NESARC
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Medical
comorbidities
Pain
Not at all**
A little bit**
Moderately
Quite a bit
Extremely
Hypertension
(P/E)**
Yes
No
Chest Pain (P/E)**
Yes
No

Total
n=8,205
Frequency / %

No Major
Depression
n=7,148 %(se)

Major
Depression
n=1,057 %(se)

OR for Major
Depression
OR (LCL, UCL)

p-value

3,637 (44.7)
1,658 (20.4)
1,069 (13.1)
1,107 (13.6)
664 (8.2)

91.58 (0.50)
87.19 (0.90)
85.65 (1.32)
79.16 (1.48)
81.28 (1.89)

8.42 (0.50)
12.81 (0.90)
14.35 (1.32)
20.84 (1.48)
18.72 (1.89)

0.40 (0.30, 0.52)
0.64 (0.48, 0.85)
0.73 (0.53, 1.00)
1.14 (0.85, 1.54)
1.00

0.00
0.00
0.05
0.37
-

3,910 (47.7)
4,295 (52.3)

85.71 (0.72)
88.83 (0.56)

14.29 (0.72)
11.17 (0.56)

1.33 (1.13, 1.56)
1.00

0.00

1,018 (12.4)
7,187 (87.6)

75.77 (1.81)
89.03 (0.44)

24.23 (1.81)
10.97 (0.44)

2.60 (2.10, 3.20)
1.00

0.00

Rapid Heart (P/E)**

Yes
No
Heart Attack (P/E)
Yes
No
Other Heart
Disease (P/E)**

0.00
925 (11.3)
7,280 (88.7)

79.09 (1.67)
88.47 (0.46)

20.91 (1.67)
11.53 (0.46)

2.03 (1.63, 2.52)
1.00
0.15

265 (3.2)
7,940 (96.8)

83.75 (2.75)
87.47 (0.47)

16.25 (2.75)
12.53 (0.47)

1.35 (0.89, 2.06)
1.00

Yes
No
Alcohol
Abuse/Depend (E)
No diagnosis
Abuse only
Abuse/Depend**
Nicotine Depend
(E)**
Yes
No

Total
n=8,205
Frequency / %
709 (8.6)
7,496 (91.4)

No Major
Depression
n=7,148 %(se)
80.82 (1.70)
88.05 (0.47)

Major
Depression
n=1,057 %(se)
19.18 (1.70)
11.95 (0.47)

OR for Major
Depression
OR (LCL, UCL)
1.75 (1.38, 2.21)
1.00

7,005 (85.4)
934 (11.4)
227 (2.8)

88.00 (0.47)
88.16 (1.26)
75.31 (3.21)

12.00 (0.47)
11.84 (1.26)
24.69 (3.21)

1.00
0.99 (0.76, 1.27)
2.40 (1.70, 3.39)

663 (8.1)
7,542 (91.9)

88.67 (0.44)
76.00 (2.03)

11.33 (0.44)
24.00 (2.03)

2.47 (1.95, 3.13)
1.00

p-value
0.00

0.90
0.00
0.00
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Comparing MDD and Depression (P)

It is important to reiterate the differences between the two dependent variables
examined within the study: MDD and depression (P). MDD was defined by the
NESARC survey which utilized a series of questions to determine the dichotomous
responses to those needed by the DSM-IV for a clinician to diagnose a patient with major
depressive disorder. Five of nine questions needed to be positive to positively account
for MDD within the study. Depression (P) was given a positive response if those seniors
surveyed responded positively to the following question, “During the past four weeks,
how often have you felt downhearted or depressed”? A positive response required that
the respondent answer either “all of the time” or “most of the time”.
Among all older adults, 7.32% reported that that they had felt "downhearted or
depressed" either all or most of the time during the past four weeks. Self-reported
depression was more common among persons who screened positive for MDD (20.40%)
than among persons who did not (5.46%) [Table 4.4, below]. It is notable that most older
adults who screened positive for depression (79.60%) did not actually self-report
depression.
Table 4.4. Overlap between MDD and Depression (P) among persons 65 and older, by
reported Arthritis (P/E), NESARC 2001-2002.
Variables

Total (%)

MDD

No MDD

Chi Squared

P
Value

90 (16.75)
42 (51.01)
132 (21.18)

17.94

.0001

Arthritis (P/E) Present (n=609; 7.42%)
Depression (P)
Yes
519 (87.06)
429 (83.25)
No
90 (12.94)
48 (48.99)
Total
477 (78.82)
Arthritis (P/E) Not Present (n=7,596; 92.58%)
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Depression (P)
Yes
No

549 (6.87)
7,047
(93.13)

Total

177 (32.18)
748 (10.22)
925 (11.73)

372 (67.82)
6,299
(89.78)
6,671
(88.27)

39.61

.0000

Multivariate Model [MDD and Depression (P)]

Model 1: MDD {DV} = logit[Arthritis (P/E) {IV of interest}]
Depression (P) {DV} = logit[Arthritis (P/E) {IV of interest}]
Model 2: MDD {DV} = logit[Arthritis (P/E) {IV of interest} + Predisposing
Characteristics + Enabling Characteristics]
Depression (P) {DV} = logit[Arthritis (P/E) {IV of interest} +
Predisposing Characteristics + Enabling Characteristics]
Model 3: MDD {DV} = logit[Arthritis (P/E) {IV of interest} + Predisposing
Characteristics + Enabling Characteristics + Biopsychosocial
Conditions]
Depression (P) {DV} = logit[Arthritis (P/E) {IV of interest} +
Predisposing Characteristics + Enabling Characteristics +
Biopsychosocial Conditions]
Model 4 : MDD {DV} = logit[Arthritis (P/E) {IV of interest} + Predisposing
Characteristics + Enabling Characteristics + Biopsychosocial
Conditions + Medical Comorbidities]
Depression (P) {DV} = logit[Arthritis (P/E) {IV of interest} +
Predisposing Characteristics + Enabling Characteristics +
Biopsychosocial Conditions + Medical Comorbidities]
Multivariate: Model 1 [MDD]

Those elderly who experienced arthritis (P/E) [OR 2.00; 95% CI: (1.52, 2.65)] were
significantly more likely to experience MDD than those who did not experience arthritis
(P/E) [Table 4.4].
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Multivariate: Model 2 [MDD]

Compared to those who did not experience arthritis (P/E), those who experienced
arthritis (P/E) [OR 1.87; 95% CI: (1.41, 2.47)] were significantly more likely to
experience MDD [Table 4.4].
Multivariate: Model 3 [MDD]

Arthritis (P/E) was significantly associated with the likelihood of MDD [OR 1.87;
95% CI: (1.31, 2.67)].
Multivariate: Model 4 [MDD]

Those elderly who experienced arthritis (P/E) [OR 1.60; 95% CI: (1.12, 2.28)] were
significantly more likely to experience MDD than those who did not experience arthritis
(P/E) [Table 4.4].
Multivariate: Model 1 [Depression (P)]

Those seniors surveyed who experienced arthritis (P/E) [OR 2.02; 95% CI: (1.52,
2.68)] were significantly more likely to experience depression (P) than those who did not
experience arthritis (P/E) [Table 4.5].
Multivariate: Model 2 [Depression (P)]

Those elderly who experienced arthritis (P/E) [OR 1.34; 95% CI: (0.98, 1.83)] were
no more likely to experience depression (P) than those who did not experience arthritis
(P/E) [Table 4.5].
Multivariate: Model 3 [Depression (P)]

Those persons suffering from arthritis (P/E) were no more likely [OR 1.40; 95% CI:
(0.96, 2.04)] to report depression (P) than those without arthritis (P/E) [Table 4.5].
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Multivariate: Model 4 [Depression (P)]

Those persons suffering from arthritis (P/E) were no more likely [OR 1.33; 95% CI:
(0.89, 1.99)] to suffer from depression (P) than those not suffering from arthritis (P/E)
[Table 4.5].
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4.3 MULTIVARIATE ANALYSIS [MDD]
Table 4.5 Factors associated with MDD among population 65 years and older, NESARC 2001-2002.
Model 1
n=8,205
N=33,764,930
%(se)
OR (95% CI)

Table Variables
Hypothesized IV
Arthritis
Predisposing
Characteristics
Place of birth
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Race

Gender
Health status

Age

Region

Yes
No

U.S. born
Non-U.S. born
Non-Hispanic
White
Non-Hispanic
Black
Hispanic
Non-Hispanic
other
Male
Female
Excellent
Very good
Good
Fair
Poor
65-74
75-84
85+
Northeast

2.00 (1.52, 2.65)**
1.00

Model 2
n=8,128
N=33,505,384
%(se)
OR (95% CI)

Model 3
n=6,384
N=26,718,861
%(se)
OR (95% CI)

Model 4
n=6,380
N=26,709,788
%(se)
OR (95% CI)

1.87 (1.41, 2.47)**
1.00

1.87 (1.31, 2.67)**
1.00

1.60 (1.12, 2.28)**
1.00

0.96 (0.71, 1.31)
1.00
1.00

0.79 (0.55, 1.13)
1.00
1.00

0.74 (0.51, 1.06)
1.00
1.00

0.60 (0.46, 0.79)**

0.71 (0.49, 1.04)

0.72 (0.48, 1.07)

0.83 (0.58, 1.20)
1.06 (0.74, 1.53)

0.92 (0.61, 1.40)
1.65 (1.10, 2.46)

0.99 (0.66, 1.49)
1.72 (1.12, 2.64)

1.00
2.26 (1.86, 2.75)**
1.00
0.96 (0.71, 1.29)
1.21 (0.90, 1.61)
1.65 (1.23, 2.20)**
2.44 (1.77, 3.38)**
1.00
0.71 (0.59, 0.85)**
0.42 (0.32, 0.56)**
1.00

1.00
2.15 (1.72, 2.69)**
1.00
0.78 (0.56, 1.08)
1.03 (0.75, 1.40)
1.31 (0.95, 1.81)
2.02 (1.38, 2.97)**
1.00
0.77 (0.62, 0.96)**
0.40 (0.27, 0.57)**
1.00

1.00
2.21 (1.74, 2.82)**
1.00
0.70 (0.50, 0.98)**
0.84 (0.60, 1.17)
0.91 (0.64, 1.30)
1.27 (0.79, 2.05)
1.00
0.81 (0.65, 1.01)
0.43 (0.29, 0.62)**
1.00

Model 1
n=8,205
N=33,764,930
%(se)

Table Variables
Midwest
South
West
Enabling
Characteristics
Education

Medicare
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Medicaid
Private Insurance
Income level

SSI income
Food stamps
Financial hardship

Some high
school/less
Complete high
school
Some college
College
graduate
Yes
No
Yes
No
Yes
No
$0-$10,000
$10,001$20,000
$20,001$30,000
$30,001$40,000
$40,001-higher
Yes
No
Yes
No
Yes
No

Model 2
n=8,128
N=33,505,384
%(se)
1.19 (0.92, 1.53)
1.12 (0.89, 1.41)
1.29 (1.01, 1.65)**

Model 3
n=6,384
N=26,718,861
%(se)
1.05 (0.79, 1.40)
1.12 (0.86, 1.46)
1.17 (0.87, 1.56)

Model 4
n=6,380
N=26,709,788
%(se)
0.99 (0.74, 1.32)
1.07 (0.81, 1.41)
1.09 (0.81, 1.47)

0.90 (0.69, 1.19)

0.89 (0.65, 1.21)

0.86 (0.63, 1.18)

0.94 (0.75, 1.18)

0.96 (0.72, 1.27)

0.95 (0.72, 1.26)

0.94 (0.70, 1.25)
1.00

0.95 (0.69, 1.32)
1.00

0.94 (0.67, 1.32)
1.00

1.24 (0.83, 1.84)
1.00
0.92 (0.66, 1.27)
1.00
1.17 (0.98, 1.40)
1.00
0.83 (0.62, 1.10)
0.98 (0.76, 1.25)

1.13 (0.72, 1.78)
1.00
0.84 (0.58, 1.22)
1.00
1.02 (0.82, 1.26)
1.00
0.86 (0.61, 1.23)
1.04 (0.77, 1.40)

1.11 (0.70, 1.74)
1.00
0.83 (0.57, 1.21)
1.00
1.02 (0.83, 1.26)
1.00
0.89 (0.63, 1.25)
1.03 (0.76, 1.40)

0.85 (0.65, 1.11)

0.88 (0.63, 1.25)

0.89 (0.63, 1.25)

0.82 (0.62, 1.10)

0.83 (0.59, 1.17)

0.84 (0.60, 1.20)

1.00
1.13 (0.79, 1.61)
1.00
1.48 (0.96, 2.30)
1.00
3.82 (2.74, 5.33)**
1.00

1.00
1.15 (0.76, 1.76)
1.00
1.23 (0.72, 2.12)
1.00
3.33 (2.19, 5.06)**
1.00

1.00
1.14 (0.75, 1.72)
1.00
1.08 (0.63, 1.86)
1.00
2.99 (1.95, 4.56)**
1.00

Table Variables
Biopsychosocial
conditions
Mother (Depressed)
Father (Depressed)
Father (Alcohol)
Mother (Alcohol)
DSI/I

102

Not open
Not help
Stubborn
Medical
comorbidities
Pain

Hypertension (P/E)
Chest pain (P/E)
Rapid heart (P/E)

Model 1
n=8,205
N=33,764,930
%(se)

Yes
No
Yes
No
Yes
No
Yes
No
None
Either
Both
Yes
No
Yes
No
Yes
No

Not at all
A little bit
Moderately
Quite a bit
Extremely
Yes
No
Yes
No
Yes

Model 2
n=8,128
N=33,505,384
%(se)

Model 3
n=6,384
N=26,718,861
%(se)

Model 4
n=6,380
N=26,709,788
%(se)

3.47 (2.56, 4.69)**
1.00
1.79 (1.21, 2.65)**
1.00
1.46 (0.72, 2.94)
1.00
1.41 (1.07, 1.87)**
1.00
0.66 (0.51, 0.85)**
1.00
1.22 (0.95, 1.58)
1.65 (1.22, 2.23)**
1.00
1.33 (1.02, 1.72)**
1.00
1.34 (1.08, 1.66)**
1.00

3.33 (2.44, 4.55)**
1.00
1.74 (1.16, 2.62)**
1.00
1.35 (0.66, 2.76)
1.00
1.34 (1.00, 1.80)
1.00
0.69 (0.54, 0.89)**
1.00
1.23 (0.95, 1.59)
1.60 (1.18, 2.16)**
1.00
1.25 (0.95, 1.64)
1.00
1.27 (1.03, 1.58)**
1.00

0.69 (0.46, 1.05)
0.90 (0.60, 1.36)
0.92 (0.58, 1.47)
1.26 (0.82, 1.93)
1.00
1.04 (0.85, 1.27)
1.00
1.63 (1.22, 2.16)**
1.00
1.14 (0.85, 1.53)

Model 1
n=8,205
N=33,764,930
%(se)
No
Yes
No
Yes

Model 4
n=6,380
N=26,709,788
%(se)
1.00
0.68 (0.35, 1.32)
1.00
0.94 (0.69, 1.28)

No
No alcohol

1.00
1.00

Abuse only
Abuse and
depend
Yes
No

1.12 (0.79, 1.60)
1.46 (0.83, 2.55)

Table 3 (Variable)
Heart attack (P/E)
Other heart disease
(P/E)
Alcohol
Abuse/Depend (E)

Nicotine Depend (E)

Model 2
n=8,128
N=33,505,384
%(se)
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** represents all significant variables with a p-value less than or equal to 0.05

Model 3
n=6,384
N=26,718,861
%(se)

1.82 (1.31, 2.51)**
1.00

Table 4.6 Factors associated with perceived depression among population 65 years and older, NESARC 2001-2002.
Model 1
n=8,205
N=33,764,930
%(se)
OR (95% CI)

Table Variables
Hypothesized IV
Arthritis
Predisposing
Characteristics
Place of birth

Yes
No

U.S. born
Non-U.S. born

Race
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Gender
Health status

Age

Region

Non-Hispanic
White
Non-Hispanic
Black
Hispanic
Non-Hispanic
other
Male
Female
Excellent
Very good
Good
Fair
Poor
65-74
75-84
85+
Northeast
Midwest
South
West

2.02 (1.52, 2.68)**

1.00

Model 2
n=8,128
N=33,505,384
%(se)
OR (95% CI)

Model 3
n=6,384
N=26,718,861
%(se)
OR (95% CI)

Model 4
n=6,380
N=26,709,788
%(se)
OR (95% CI)

1.34 (0.98, 1.83)
1.00

1.40 (0.96, 2.04)
1.00

1.33 (0.89, 1.99)
1.00

0.67 (0.45, 0.99)**
1.00
1.00

0.60 (0.38, 0.95)**
1.00
1.00

0.58 (0.37, 0.91)**
1.00
1.00

0.76 (0.57, 1.02)

0.79 (0.53, 1.17)

0.81 (0.54, 1.22)

0.82, 0.55, 1.22)
0.95 (0.49, 1.85)

0.93 (0.58, 1.48)
1.11 (0.56, 2.20)

0.96 (0.60, 1.54)
1.15 (0.58, 2.30)

1.00
1.30 (1.05, 1.61)**
1.00
1.23 (0.69, 2.18)
1.67 (0.96, 2.90)
3.00 (1.73, 5.21)**
8.92 (5.13, 15.51)**
1.00
0.93 (0.73, 1.19)
0.90 (0.64, 1.26)
1.00
0.90 (0.66, 1.22)
1.04 (0.78, 1.37)
0.87 (0.60, 1.25)

1.00
1.25 (0.99, 1.58)
1.00
1.22 (0.62, 2.37)
1.64 (0.87, 3.11)
2.64 (1.42, 4.92)**
8.12 (4.20, 15.71)**
1.00
0.93 (0.70, 1.23)
0.99 (0.66, 1.48)
1.00
0.84 (0.58, 1.22)
0.94 (0.66, 1.36)
0.82 (0.53, 1.26)

1.00
1.22 (0.95, 1.57)
1.00
1.09 (0.56, 2.12)
1.35 (0.70, 2.58)
1.71 (0.90, 3.24)
4.08 (1.99, 8.36)**
1.00
0.92 (0.70, 1.22)
1.07 (0.71, 1.60)
1.00
0.80 (0.55, 1.14)
0.89 (0.63, 1.27)
0.77 (0.51, 1.18)

Table 3 (Variable)
Enabling
Characteristics
Education

Medicare
Medicaid
Private Insurance
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Income level

SSI income
Food stamps
Financial hardship

Model 1
n=8,205
N=33,764,930
%(se)

Some high
school/less
Complete high
school
Some college
College graduate
Yes
No
Yes
No
Yes
No
$0-$10,000
$10,001-$20,000
$20,001-$30,000
$30,001-$40,000
$40,001-higher
Yes
No
Yes
No
Yes
No

Biopsychosocial
conditions
Mother (Depressed)

Yes

Model 2
n=8,128
N=33,505,384
%(se)

1.65 (1.13, 2.42)**
1.29 (0.90, 1.86)
0.89 (0.57, 1.39)
1.00
1.39 (0.87, 2.21)
1.00
1.11 (0.80, 1.55)
1.00
0.72 (0.57, 0.92)**

1.00
0.89 (0.57, 1.38)
1.13 (0.76, 1.68)
0.95 (0.63, 1.44)
0.97 (0.60, 1.55)
1.00
1.25 (0.85, 1.82)
1.00
1.18 (0.70, 1.99)
1.00
3.24 (2.20, 4.77)
1.00

Model 3
n=6,384
N=26,718,861
%(se)

Model 4
n=6,380
N=26,709,788
%(se)

1.63 (1.04,
2.57)**
1.30 (0.86, 1.97)

1.57 (0.99, 2.48)

0.87 (0.54, 1.41)
1.00
1.42 (0.78, 2.60)
1.00
0.99 (0.65, 1.51)
1.00
0.69 (0.52, 0.90)
1.00
1.20 (0.72, 1.99)
1.37 (0.88, 2.15)
1.21 (0.75, 1.95)
1.30 (0.76, 2.24)
1.00
1.29 (0.81, 2.06)
1.00
1.14 (0.57, 2.32)
1.00
3.39 (2.17,
5.31)**
1.00

0.86 (0.53, 1.42)
1.00
1.43 (0.80, 2.55)
1.00
0.97 (0.63, 1.49)
1.00
0.71 (0.54, 0.93)
1.00
1.23 (0.75, 2.02)
1.39 (0.89, 2.17)
1.28 (0.80, 2.06)
1.33 (0.77, 2.31)
1.00
1.36 (0.86, 2.17)
1.00
1.02 (0.52, 2.03)
1.00
2.98 (1.90, 4.68)**

1.14 (0.72, 1.80)

1.11 (0.68, 1.79)

1.29 (0.85, 1.95)

1.00

Model 1
n=8,205
N=33,764,930
%(se)

Table 3 (Variable)
Father (Depressed)
Father (Alcohol)
Mother (Alcohol)
DSI/I

Not open
Not help
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Stubborn
Medical
comorbidities
Pain

Hypertension (P/E)
Chest pain (P/E)
Rapid heart (P/E)
Heart attack (P/E)

No
Yes
No
Yes
No
Yes
No
None
Either
Both
Yes
No
Yes
No
Yes
No

Model 2
n=8,128
N=33,505,384
%(se)

Model 3
n=6,384
N=26,718,861
%(se)
1.00
1.74 (0.97, 3.12)
1.00
1.77 (0.82, 3.80)
1.00
1.12 (0.78, 1.60)
1.00
0.98 (0.74, 1.29)
1.00
1.31 (0.94, 1.82)
1.37 (0.93, 2.03)
1.00
1.18 (0.82, 1.70)
1.00
1.16 (0.88, 1.52)
1.00

Model 4
n=6,380
N=26,709,788
%(se)
1.00
1.72 (0.93, 3.18)
1.00
1.66 (0.77, 3.58)
1.00
1.10 (0.76, 1.60)
1.00
1.06 (0.79, 1.42)
1.00
1.34 (0.95, 1.89)
1.35 (0.90, 2.02)
1.00
1.10 (0.76, 1.61)
1.00
1.09 (0.83, 1.44)
1.00

Not at all
A little bit
Moderately
Quite a bit
Extremely
Yes
No
Yes
No
Yes

0.25 (0.17, 0.37)**
0.36 (0.24, 0.55)**
0.38 (0.24, 0.62)**
0.65 (0.45, 0.95)**
1.00
1.07 (0.81, 1.42)
1.00
1.05 (0.73, 1.52)
1.00
1.30 (0.92, 1.83)

No
Yes
No

1.00
0.93 (0.54, 1.60)
1.00

Table 3 (Variable)
Other heart disease
(P/E)
Alcohol
Abuse/Depend (E)

Nicotine Depend (E)

Model 1
n=8,205
N=33,764,930
%(se)

Model 2
n=8,128
N=33,505,384
%(se)

Yes

Model 4
n=6,380
N=26,709,788
%(se)
0.73 (0.50, 1.08)

No
No alcohol

1.00
1.00

Abuse only
Abuse and
depend
Yes
No

1.33 (0.89, 1.99)
1.27 (0.56, 2.90)

** represents all significant variables with a p-value less than or equal to 0.05

Model 3
n=6,384
N=26,718,861
%(se)

1.12 (0.70, 1.80)
1.00
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CHAPTER FIVE: DISCUSSION
5.1 BACKGROUND
The purpose of this study was to explore both positive screened MDD and the
perception of being depressed (P) and the likelihood of either increasing if the patient
suffered from arthritis (P/E), either perceived or evaluated by a physician. The study
explored the univariate, bivariate, and multivariate relationships between MDD and
depression (P) to better describe influencing characteristics and their prevalence, as
related to MDD and depression (P).
5.2 SUMMARY
It is important to reiterate the differences between the two dependent variables
examined within the study: MDD and depression (P). MDD was a positive screening
variable that was developed from the NESARC survey which utilized a series of
questions to determine the dichotomous responses to those needed by the DSM-IV for a
clinician to diagnose a patient with major depressive disorder. Five of nine questions
needed to be positive to positively account for MDD within the study. Depression (P)
was given a positive response if those seniors surveyed responded positively to the
following question, “During the past four weeks, how often have you felt downhearted or
depressed”? A positive response required that the respondent answer either “all of the
time” or “most of the time”.
Among all older adults, 7.32% reported that that they had felt "downhearted or
depressed" either all or most of the time during the past four weeks. Self-reported
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depression was more common among persons who screened positive for MDD (20.40%)
than among persons who did not (5.46%). It is notable that most older adults who
screened positive for depression (79.60%) did not actually self-report depression.
The following were the hypotheses projected and comments regarding their overall
outcomes with the study:
H1: Those persons age 65 and older who report having arthritis (P/E) will be significantly
more likely to be suffering from MDD than those who have not reported having an
arthritic condition (P/E) [results were positive within Models 2-4].
H2: Those persons age 65 and older who report having arthritis (P/E) will be significantly
more likely to be suffering from depression (P) than those who have not reported having
an arthritic condition (P/E) [results were negative within Models 2-4].
This creates significant concern, given that each of the multivariate models (2-4)
examined arthritis (P/E) while utilizing the same control variables throughout. Further,
many of the relationally significant variables in the MDD versus depression (P) models
were not the same (Table 4.4 /4.5).
5.3 LIMITATIONS OF THE STUDY
There were several limitations to the study which need to be addressed. NESARC
was surveyed from 2001-02 so the outcome data are beginning to become dated. The
depression (P) variable was recoded to include a dichotomous variable included the
following two response options: (1) all of the time/most of the time (2) all other
responses. This was done to utilize multiple logistic regression to analyze Models 1-3 in
the multivariate model. Some of the selection variables were somewhat limited in
response size, given that their subcategories were greater than three. Lastly, the study
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was originally intended to be an alcohol and drug survey collection tool so the overall
sample population selection and survey questioning and administration could not be
reviewed for quality.
5.4 CONCLUSIONS
Those seniors who suffer from arthritis (P/E) were more likely to also suffer from
MDD in all models tested. However, those same seniors were not more likely to suffer
from arthritis (P/E) in all models (2-4) when analyzing depression (P). Further, the
bivariate relationship between MDD and the control variables conclusively expressed
differing results within the multivariate analysis than did those expressed between
depression (P) and arthritis. This study examined arthritis (P/E) and their comparable
relationship to whether the senior suffered from either MDD or depression (P). The
results demonstrated conclusive evidence that one cannot count on an elderly patient to
have a positive perception of depression as it relates to being positively screened for
MDD. Further, it would appear that older persons may not disclose whether or not they
are depressed in a clinical environment. This becomes important to clinicians and further
demonstrated the need for clinically valid assessment measures to ensure preventative
measures are being taken to address elderly depression.
5.5 RECOMMENDATIONS
The variations between the multivariate models (2-4) outcomes and the two
dependent variables [MDD and depression (P)] suggest further investigation into dependent
variable differences is needed. Primarily, a cross sectional review outlining the
differences between MDD and depression (P) and those variables in which stratification
could provide some account for demonstrated differences throughout this study.

110

Gender needs to be further investigated, given its significance in Models 2-4 (all
multivariate models) when modeled with MDD. Further, gender was not significant in
any of the depression (P) multivariate models. In Model 4, women were significantly
more likely to suffer from MDD than men [OR 2.21; 95% CI: (1.74, 2.82)], however, no
significance was reported in Model 4 when control variables examined with depression
(P) [OR 1.22; 95% CI: (0.95, 1.57)]. The differences between gender and depression for
those 65 years old and greater would add clinical value for those practitioners attempting
to better understand gerontology and mental health treatment.
The biological relationship between those with MDD and having reported their
mother being depressed needs further study. In Model 4, those who reported their
biological mother being depressed were significantly more likely to suffer from MDD
[OR 3.33; 95% CI: (2.44, 4.55)]. Conversely, in the depression (P) Model 4, someone
reporting that their biological mother was depressed were no more likely to perceive
themselves as depressed [OR 1.11; 95% CI: (0.68, 1.79)].
Those experiencing financial hardship were significantly more likely to suffer from
MDD and to perceive themselves as being depressed. This was significant in all
multivariate models when either MDD or depression (P) was the dependent variable
being examined.
Another area of future study would be the oldest old (85+) ability to be significantly
less likely to be suffering from MDD than the youngest old (65-74) [OR 0.43; 95% CI:
(0.29, 0.62). This perhaps could lead to the development of coping mechanism
techniques in which the oldest old demonstrate or disclose learned behaviors for dealing
with medical issues and the aging process.
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The final area of recommendation for further study would be concerning a patient’s
perception with regards to pain and its impact on those who have arthritis. In the MDD
study, those who reported pain (all levels) were no more likely to suffer from MDD.
However, those who reported pain (all levels) were significantly more likely to selfreport being depressed.
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